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SAMMENDRAG 
Friske gravide anbefales å trene regelmessig under svangerskapet for å fortsette å oppnå de 
samme helsegevinstene som ved trening i ikke-gravid tilstand. Når det gjelder forebygging og 
behandling av svangerskapsrelaterte plager, har det ikke tidligere vært gjennomført store 
randomiserte kontrollerte studier for å studere mulig effekt av trening i svangerskapet. Dagens 
kunnskap er hovedsakelig basert på observasjonsstudier. 
 
TRIP-studien er en to-armet, to-senter, randomisert kontrollert studie og ble gjennomført i 
perioden 2007-2010. Studien inkluderte 855 friske, gravide kvinner fra Trondheim og 
Stavanger. Kvinnene ble tilfeldig fordelt i en treningsgruppe og i en kontrollgruppe. Kvinnene 
i treningsgruppen ble tilbudt et 12-ukers standardisert treningsprogram med ukentlig 
gruppetrening, ledet av fysioterapeut, og to dager egentrening. Kvinnene i kontrollgruppen 
fulgte vanlig svangerskapsomsorg. Kvinnene ble testet i svangerskapsuke 18-22 og retestet i 
svangerskapsuke 32-36. 
 
Målet med denne studien var: I) å undersøke om deltagelse i treningsprogrammet kunne 
redusere forekomsten av svangerskapsdiabetes og gi bedre insulinresistens, II) å undersøke 
om kvinner i treningsgruppen rapporterte mer rygg- og bekkensmerter enn kvinner i 
kontrollgruppen, III) å undersøke om kvinner i treningsgruppen som ble tilbudt et generelt 
treningsprogram inkludert bekkenbunnstrening, rapporterte mindre inkontinens enn 
kontrollgruppen og IV) å undersøke om energiforbruket, målt med en fysisk aktivitets-
monitor, SenseWearTM Pro2 Armband, er forskjellig fra energiforbruket målt med indirekte 
kalorimetri. 
 
Totalt 55 % av kvinnene i treningsgruppen trente tre ganger per uke eller mer på moderat til 
høy intensitet på slutten av svangerskapet. Til sammenligning trente 10 % i kontrollgruppen 
tilsvarende (p<0.001). I) Det var ingen forskjell på gruppene i forekomst av 
svangerskapsdiabetes eller insulinresistens. II) Andelen kvinner med rygg- og bekkensmerter 
var lik i begge gruppene, men færre kvinner i treningsgruppen var sykmeldt på grunn av rygg- 
og bekkensmerter. III) Forekomsten av urininkontinens var mindre i treningsgruppen, og 
treningsprogrammet viste seg å ha både forebyggende og behandlende effekt. Det var ingen 
forskjell på gruppene i andel kvinner som rapporterte analinkontinens. IV) SenseWearTM Pro2 
Armband viste seg å være en god fysisk aktivitetsmonitor for å registrere totalt energiforbruk 
hos gravide. 
 
Resultater fra TRIP-studien understøtter de generelle anbefalingene om at gravide kvinner bør 
trene i svangerskapet. En grundig instruksjon i korrekt bekkenbunnstrening og et 
bekkenbunnstreningsprogram bør inngå i treningsgrupper for gravide kvinner. 
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 SUMMARY 
Healthy pregnant women are encouraged to engage in regular exercise during pregnancy to 
continue to derive same health benefits as in the non-pregnant state. However, as research on 
exercise during pregnancy is mainly based on observational studies, there is a lack of large- 
scale randomized controlled trials to evaluate the role of exercise during pregnancy in the 
prevention and treatment of pregnancy-related conditions. 
 
The TRIP trial was a two-armed, two-centered randomized controlled trial conducted in 2007-
2010. The trial included 855 healthy pregnant women from the areas of Trondheim and 
Stavanger in Norway. Women were randomized to an intervention or control group. Women 
in the intervention group were offered a 12-week standardized exercise program with weekly 
group training led by a physiotherapist and a training program to be performed twice per week 
at home. Women in the control group received standard antenatal care. Women were enrolled 
at 18-22 weeks of pregnancy and follow-up was done at 32-36 weeks of pregnancy. 
 
The aims of this trial were: I) to assess the efficacy of offering pregnant women a regular 
exercise program to prevent gestational diabetes and improve insulin resistance, II) to assess 
if women randomized to a regular exercise program were more likely to report lumbopelvic 
pain than women receiving standard antenatal care, III) to assess if pregnant women 
following a general exercise course including pelvic floor muscle training were less likely to 
report incontinence in late pregnancy than a group of women receiving standard antenatal 
care, and IV) to assess whether the energy expenditure recorded with the physical activity 
monitor SenseWearTM Pro2 Armband differs from that recorded with indirect calorimetry. 
 
The adherence to the protocol (exercising three days per week or more at moderate to high 
intensity) in the intervention group was 55 %. By comparison, 10 % in the control group 
exercised three days per week at moderate to high intensity at follow-up (p<0.001). I) There 
was no difference between groups in the prevalence of gestational diabetes or level of insulin 
resistance. II) The prevalence of lumbopelvic pain in both groups was similar, however, less 
women in the intervention group were on sick leave due to lumbopelvic pain. III) The 
intervention group reported less urinary incontinence in late gestation, and the intervention 
had both a primary and secondary prevention effect. No difference was found in anal 
11
 incontinence between groups. IV) The physical activity monitor SenseWearTM Pro2 Armband 
was found to be a valid instrument in pregnant women. 
 
The TRIP trial supports the general recommendations that women should engage in regular 
exercise during pregnancy and that thorough instructions in pelvic floor muscle training and a 
pelvic floor muscle training program should be included in general exercise classes for 
pregnant women.  
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 INTRODUCTION  
During the last 20 years there has been increasing interest in the possible benefits of exercise 
in pregnancy, and pregnant women are encouraged to exercise throughout the pregnancy. 
However, today’s knowledge about the importance of regular exercise in pregnancy is mainly 
based on results from observational studies. This thesis examines the effect of regular exercise 
during pregnancy based on a randomized controlled trial (RCT) performed in the period 2007-
2010 including 855 pregnant women. 
 
Definitions 
Physical activity is defined as any bodily movement produced by skeletal muscles that results 
in energy expenditure.62 Exercise is a subset of physical activity that is planned, structured, 
and repetitive and has  as objective to improve or maintain physical fitness.62 Physical activity 
and exercise promote health and longevity, and minimal adherence to current physical activity 
guidelines is associated with a significant 20-30 % reduction in risk of all-cause mortality.185 
Further reductions in risk are observed at higher volumes of energy expenditure.185 Disease 
outcomes and conditions inversely related to regular physical activity include cardiovascular 
disease, thromboembolic stroke, hypertension, type 2 diabetes mellitus (T2DM), osteoporosis, 
some form of cancers (colon and breast cancer), anxiety, depression and obesity.163  
 
According to the World Health Organization (WHO) physical inactivity has been identified as 
the fourth leading risk factor for global mortality causing an estimated 3.2 million deaths 
globally.338 Among women of reproductive age in the US, physical inactivity declined from 
25 % to 23 %, however, obesity increased from 18 % to 25 % from 2001/2003 to 2009.143  
 
 
History 
Recognizing the beneficial effects of exercise during pregnancy is not new. In 1901, J. W. 
Ballantyne, who helped pioneer antenatal care in Edinburgh, designed a card to make sure 
essential advice during pregnancy was remembered and recorded by his “pre-maternity 
nurses”. This included a tick box regarding exercise and rest.22 In 1985, the American College 
of Obstetricians and Gynecologists (ACOG) issued a technical bulletin regarding exercise 
13
 during pregnancy.14 Women were advised to reduce physical activity levels and non-
exercising women were to refrain from initiating strenuous exercise programs. The maximum 
heart rate during pregnancy should not exceed 140 beats per minute and women should not 
take part in strenuous exercise for more than 15 minutes.14 This advice was based on concerns 
that exercise would have negative effect on the mother and fetus secondary due to increased 
core temperature during embryogenesis, circulating stress hormones, biomechanical stress and 
increased risk of maternal musculoskeletal injury due to changes in posture and ligamentous 
laxity, and by shunting the transport of oxygen and nutrients to maternal skeletal muscles 
rather than to the developing fetus.83 The recommendations were primarily based on expert 
opinions because of limited evidence available at that time. 
 
Following these original ACOG guidelines, research over the next 10 years focused on the 
safety, as well as the potential benefit of physical activity performed during the peripartum 
period. Results from most studies showed that any effects of physical activity on the maternal-
fetal unit are likely to be beneficial. In 1994, ACOG released a new bulletin removing specific 
limitations and prohibitions regarding exercise during pregnancy.13 ACOG still recommended 
that women should avoid exhaustion during exercise. In 2002, ACOG published “Exercise 
during pregnancy and the postpartum period: ACOG Committee Opinion 267.” In this paper, 
the ACOG Committee recognized that “in the absence of contraindications, pregnant women 
should be encouraged to engage in regular, moderate intensity physical activity to continue to 
derive health benefits during their pregnancy as they did prior to their pregnancy”.5 
 
 
Physiology 
There are profound anatomical, physiological (Figure 1), and biochemical adaptations to 
pregnancy. Many of these remarkable changes begin soon after fertilization and continue 
throughout gestation, and most occur in response to physiological stimuli provided by the 
fetus and placenta.80 These profound cardiovascular system alterations  occur in pregnant 
women regardless of their physical fitness status.207 Within five weeks of pregnancy cardiac 
output increases and reaches 24 % above the non-pregnant level in pregnancy week 24,153 and 
almost 50 % above the non-pregnant level in pregnancy week 32.270 This occurs as a result of 
increased resting heart rate by 10 beats/min,295 increased blood volume,100,153,260,337 and 
decreased mean arterial pressure.100,190 At term, the average increase in blood volume is 48 
14
 %.260 The uterine artery volume blood flow and the fraction of cardiac output distributed to 
the uterine circulation are doubled from gestational week 22 until term.109 The cardiovascular 
adaptations are associated with autonomic nervous system changes.295 The morphologic and 
functional changes are explained by increased left ventricular mass and increased wall 
thickness.153,190 The increased blood volume is mainly due to increased plasma volume 
resulting in a relative maternal anemia.337 Additionally, a decrease in systemic vascular 
resistance is seen due to increased uterine vasculature, uteroplacental circulation, and the 
decrease in vascular resistance of predominantly the skin and kidney.109,254,316 Most important 
maternal cardiovascular adaptations to pregnancy take place in the first eight weeks of 
pregnancy.100 
               
Figure 1. Illustration of pregnancy-related physiologic changes. 
 
The maternal cardiovascular adaptations have several functions and appear to establish a 
circulatory reserve necessary to provide nutrients and oxygen to both mother and fetus at rest 
and during moderate physical activity.80 
 
The growing uterus causes the diaphragm to rise about 4 cm, the transverse diameter of the 
thoracic cage increases approximately 2 cm, and the thoracic circumference increases about 6 
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 cm.80 As a consequence of the elevated diaphragm, the functional residual capacity, the 
residual volume and the peak expiratory flow rates decline progressively as gestation 
advances.135 There is increased oxygen uptake and an increase in baseline oxygen 
consumption.172 The subjective workload and maximum exercise performance decreases due 
to increased resting oxygen requirements. Because of the increased work of breathing, caused 
by pressure of the enlarged uterus on the diaphragm, there is decreased oxygen availability for 
the performance of aerobic exercise during pregnancy.18 
 
The fetal body temperature is about 1.0 °C higher than maternal temperature. To prevent 
hyperthermia during exercise due to maternal basal metabolic rate and heat production, a 
steady state of heat production versus dissipation is accomplished by increased conductance 
of heat from the core to the periphery circulation as well as through evaporative cooling 
through sweat.18  
 
Due to the enlarged uterus, the supine resting position and motionless standing will decrease 
venous return and cardiac output due to vena cava compression.74,158 However, exercise in a 
supine position has not been found to significantly decrease venous return and cardiac 
output,158 and does not support guidelines advising against exercises in supine position after 
16 weeks of gestation.5,83 However, when designing exercise programs for pregnant women 
one should be aware of the possible obstruction of vena cava.  
 
 
Exercise recommendations for non-pregnant women 
In 1995, the Centers for Disease Control and Prevention (CDC) and the American College of 
Sports Medicine (ACSM), issued a public health recommendation about physical activity with 
the purpose to encourage increased participation in physical activity by a largely sedentary US 
population.247 The original recommendations issued that “every US adult should accumulate 
30 minutes or more of moderate-intensity physical activity on most, preferably all, days of the 
week”.247 However, the recommendations were not accepted by some and others have 
misinterpreted the recommendations. In 2007, the ACSM and the American Heart Association 
issued an updated version of the 1995 recommendations.137 The intent was to provide a more 
comprehensive and explicit public health recommendation for adults based upon available 
evidence of the health benefits of physical activity.137  
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 In the latest recommendations for adults, both aerobic physical activity and strength exercises 
are recommended to promote and maintain good health and physical independence.137 
Moderate-intensity aerobic physical activity for a minimum of 30 minutes should be 
performed on five days each week or vigorous-intensity aerobic activity for a minimum of 20 
minutes on three days each week. A combination of moderate- and vigorous intensity activity 
can be performed to meet this recommendation.137 Activities that maintain or increase 
muscular strength and endurance should be performed for a minimum of two days each week. 
It is recommended that 8-10 exercises are performed on two or more nonconsecutive days 
each week using the major muscle groups.137 It is further stated that participation in aerobic 
and muscle-strengthening physical activities above minimum recommended amounts provides 
additional health benefits and results in higher levels of physical fitness.137 
 
 
Exercise recommendations for pregnant women 
From the traditional view that pregnant women should reduce their habitual levels of exercise 
in pregnancy, there is now agreement that healthy pregnant women should be encouraged to 
include exercise as part of a healthy lifestyle. Pregnancy is recognized as a unique time for 
behavior modification and is no longer considered a condition for confinement. It is currently 
recognized that habits adopted during pregnancy could affect a woman’s health for the rest of 
her life.18 Current ACOG guidelines for exercise during pregnancy recommend 30 minutes or 
more of moderate exercise on most if not all days of the week for pregnant women in the 
absence of medical or obstetric complications.5 Women with complicated pregnancies have 
been discouraged from participating in exercise activities for fear of impacting the underlying 
disorder or maternal or fetal outcome.83 The recommendations also promote exercise for 
sedentary women and those with medical or obstetric complications, but only after medical 
evaluation and clearance (Table 1). Pregnant women should be cautious about participating in 
contact sports and avoid scuba diving. Due to the anatomical and physical changes during 
pregnancy, such as weight gain, increased forces across hip- and knee joints and altered levels 
of hormones, pregnant women are theoretically more predisposed to musculoskeletal injuries. 
Nevertheless, these possibilities should be considered when designing exercise programs. 
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 Table 1. Absolute contraindications, relative contraindications and warning signs to terminate 
exercise during pregnancy. 
Absolute contraindications to 
aerobic exercise during 
pregnancy 
Relative contraindications 
to aerobic exercise during 
pregnancy 
Warning signs to 
terminate exercise 
during pregnancy 
• Hemodynamically significant heart 
disease 
• Restrictive lung disease 
• Incompetent cervix/cerclage 
• Multiple gestation at risk for 
premature labor 
• Persistent second- or third-trimester 
bleeding 
• Placenta previa after 26 weeks of 
gestation 
• Premature labor during the current 
pregnancy 
• Ruptured membranes 
• Preeclampsia/pregnancy-induced 
hypertension 
 
• Severe anemia 
• Unevaluated maternal cardiac 
arrhythmia 
• Chronic bronchitis 
• Poorly controlled type 1 diabetes 
• Extreme morbid obesity 
• Extreme underweight (BMI <12) 
• History of extremely sedentary 
lifestyle 
• Intrauterine growth restriction in 
current pregnancy 
• Poorly controlled hypertension 
• Orthopedic limitations 
• Poorly controlled seizure disorder 
• Poorly controlled hyperthyroidism 
• Heavy smoker 
• Vaginal bleeding 
• Dyspnea prior to exertion 
• Dizziness 
• Headache 
• Chest pain 
• Muscle weakness 
• Calf pain or swelling (need to 
rule out thrombophlebitis) 
• Preterm labor 
• Decreased fetal movement 
• Amniotic fluid leakage 
 
From “ACOG Committee Opinion No. 267: Exercise During Pregnancy and the Postpartum 
Period”.5 
 
Pregnant women are advised to participate in moderate intensity exercises.5 Given the 
variability in maternal heart rate responses to exercise, target heart rates cannot be used to 
monitor exercise intensity in pregnancy. However, ratings of perceived exertion have been 
found to be useful during pregnancy as an alternative to heart rate monitoring of exercise 
intensity.253 For moderate exercise, ratings of perceived exertion should be 12-14 (somewhat 
hard)18 on a 6-20 scale (Borg scale).40 Evidence of the efficacy of this approach is that, when 
exercise is self-paced, most pregnant women will voluntarily reduce their exercise intensity as 
pregnancy progresses.206  
 
 
Disease prevention 
Recently, researchers have begun to consider the role of physical activity in prevention of 
chronic diseases for both mother and offspring.255 Over the last 30 years, a substantial body of 
literature has emerged suggesting that adverse conditions during intrauterine development 
may have lasting effects on physiology and metabolism of the fetus, resulting in increased 
disease susceptibility as an adult.79 The long-term effects of fetal growth on adult health are 
thought to be the consequences of programming. A programming effect describes a stimulus 
occurring at a critical sensitive period of early life that has permanent effects on the growth 
18
 and metabolism of the organism. These stimuli may lead to alterations in birth size and 
metabolic changes, such as reduced insulin sensitivity and increased susceptibility to disease 
later in life.26 Fetal adaption to an adverse intrauterine environment involves programming of 
metabolic pathways that might predispose to cardiovascular disease in later life. This adverse 
environment may change gene expression, leading to physiological phenotypes associated 
with morbidity and mortality.27,160 Many of the genes epigenetically influenced by nutrition 
are also affected by exercise or are involved in metabolic processes that are modulated by 
exercise.204 It is therefore reasonable to hypothesize that exercise during pregnancy also could 
mediate future health outcomes through epigenetic modifications.96 
 
Body size at birth is the best available marker for fetal growth and is a rough indicator of the 
in utero environment. Both high and low birth weight has been found to have adverse 
associations with later disease. There is a robust relationship between low birth size and all-
cause mortality in adulthood, implicating a major impact of intrauterine conditions on health 
during later life.160 In a recently published meta-analysis Risnes et al.264 found that birth 
weight was inversely associated with adult mortality from all causes and cardiovascular 
mortality. For cancer mortality there was a linear relationship with birth weight for men, but 
not for women.  
 
Children with a high birth weight are more likely to become obese.16,335 In the long run, 
childhood overweight and obesity is strongly associated with adult obesity, giving more than 
a fivefold increase in the risk for being overweight in early adulthood.122,296,311 These results 
suggest that prevention of obesity should begin as early as possible.  
 
There is now increasing evidence that the effect of the in utero environment on the 
development of obesity and risk factors for adult disease is U-shaped. Here, the rates of 
T2DM among persons with low birth weight (<2500 g) and persons with high birth weight 
(>4500 g) are being almost twice as high compared to persons with normal birth weight.238,252 
Hopkins et al.151 found that women who exercised regularly from gestational week 20 
onwards gave birth to significantly lighter babies than controls (3426 ± 427 vs. 3569 ± 433). 
Clapp et al.73 found that women who performed a high volume of exercise in early pregnancy 
and then cut back their exercise in late pregnancy delivered offspring who were significantly 
heavier at birth. In contrast, although not statistically significant, the offspring of women who 
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 increased from a low volume of exercise in early pregnancy to a high volume in the second 
half of pregnancy were on average 100 g lighter than the offspring of a comparative group 
who maintained a moderate volume of exercise throughout pregnancy. These results suggest 
that fetoplacental adaptations are dependent on the period of gestation in which exercise 
training is initiated and maintained, as well as the intensity or volume of the exercise 
performed.152 
 
In utero exposure to hyperglycemia is found to have an intergenerational effect, with women 
born to diabetic mothers being more predisposed to diabetes in their own pregnancy than 
women born to non-diabetic mothers.205 Promoting the health of women of reproductive age 
before conception and ensuring that women receive the services they need to improve 
outcomes while they are pregnant is a primary goal of preconception care and the prevention 
of chronic diseases in future generations.20 Helping women to maintain a healthy weight 
before and during pregnancy may be the best hope for controlling the obesity epidemic seen 
in some countries. 
  
Today’s recommendations for exercise in pregnancy are proactive,5,230 suggesting that 
virtually all women having a normal pregnancy can benefit from a physical activity program. 
However, there is a lack of studies examining the potential epigenetic programming effects of 
exercise during pregnancy.96 
 
 
Pregnancy and level of physical activity 
Although exercise is recommended during pregnancy, it is documented that being pregnant is 
an event that leads to decreased physical activity. Women seem to reduce all levels of 
physical activity such as household tasks, care giving and active living, but the largest 
reduction is seen in participation in sports and exercise.105 In the Norwegian Mother and Child 
Cohort Study (MoBa study), including 34,508 pregnancies in Norway, the proportion of 
regular exercise defined as exercising three times per week or more, was 46 % before 
pregnancy and declined to 28 % and 20 % by gestational weeks 17 and 30, respectively.244 
Multiple pregnancy, pelvic girdle pain, nausea, musculo-skeletal pain, uterine contractions 
and sick-leave were factors inversely associated with regular exercise in the MoBa study.244 
Sociodemographic characteristics positively associated with exercising during pregnancy are 
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 high education, low body mass index (BMI), primiparity and being a cohabitant.60,105,149,244 
Regular exercise prior to pregnancy is strongly associated with regular exercise during 
pregnancy, and women with high levels of pre-pregnancy physical activity are more likely to 
exercise during pregnancy.60,105,149,244 
 
 
Beliefs and behavior 
In a qualitative study of 19 Australian pregnant women, motivating factors that facilitated 
women’s engagement in physical activity included access to exercise classes, using a personal 
trainer, receiving advice from health professionals, being with other pregnant women, 
wanting to stay in shape with a controlled weight gain, and receiving reassurance that their 
pregnancy was progressing satisfactorily. In addition control of physiological events such as 
constipation and incontinence, and the baby’s well-being were motivating factors.72  The 
same study identified barriers to be physical active such as feeling unwell or tired, physical 
discomforts, such as backache and sore knees, pressure from the uterus, breathlessness and 
decreased motivation and lack of time because of work and having previous children.72  
 
Most women report that they obtain the information about exercise in pregnancy from books, 
the web, parental magazines, publications issued free at antenatal clinics, and health care 
professionals.72,75 In a study by Clarke et al.,75 only 18 % reported receiving advice directly 
from the health professionals involved in their antenatal care. Women reported that the 
information received was often unclear, confusing, inconsistent or conflicting.72,75 On the 
other hand, women who are informed about the benefits and risks of physical activity and 
exercise techniques, have more favorable attitudes towards physical activity.60 
 
Following the reduction in activity during pregnancy, the activity levels are found to be 1.4 
hours per week below pre-pregnancy levels at six months postpartum. This is associated with 
increased body weight retention during the first six months of the postpartum period.250 
Several factors related to the time available for exercise predicted the likelihood of 
insufficient activity, including employment, number of children at home, and child care 
barriers.250 Women who temporary halt exercise during pregnancy, tend not to resume their 
exercise habits postpartum to the same extent as women who continue exercising during 
pregnancy.103 
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 Among pregnant women the importance of rest and relaxation are rated significantly higher 
than having an active lifestyle and exercising regularly.75 Although most mothers understand 
the benefits of physical activity in pregnancy, that does not seem to translate in to practice. 
The pregnancy and the postnatal periods are prime opportunities for raising women’s 
awareness of health strategies to enable them to nurture their optimal well-being.72 There is 
considerable scope for improving the quantity and quality of advice in this area.75 Antepartum 
care providers should increase women’s awareness of the benefits of activity in pregnancy, 
provide reassurance about safety concerns, and present options to women that can guide their 
incorporation of recommended activity levels into their daily lives.72 
 
 
Validation of physical activity 
Physical activity is characterized by its intensity, duration, frequency and mode of activity.218 
Ideally, all these aspects should be recorded during physical activity measurements. However, 
in most studies addressing effects of physical activity in pregnancy, the validity of activity 
reports is open to discussion.  
 
Data collection of physical activity most frequently involves self-reporting (subjective) 
measures, such as questionnaires, diaries, logs, surveys and interviews. The benefits of self-
reporting measures are their practicality, low cost, low participant burden and general 
acceptance.94 However, the self-reporting methods have limitations such as recall and 
response bias and the inability to capture the absolute level of physical activity.259 Direct 
measures are believed to offer more precise estimates of energy expenditure and remove 
many of the issues of recall and response bias. There are several methods for assessing direct 
physical activity such as calorimetry (i.e., doubly labelled water, indirect, direct), 
physiological markers (i.e., cardiorespiratory fitness, biomarkers), motion sensors and 
monitors (i.e., accelerometers, pedometers, heart rate monitors).259 However, there is no 
single “golden standard” for measuring physical activity or assessing its validity.94 
 
A systematic review included 148 studies on non-pregnant adults and reported the correlation 
between self-reports and direct measurements of physical activity. However, there was no 
clear trend in the degree of correlation between self-reported and directly measured physical 
activity, regardless of the direct method used. The correlation was generally low-to-moderate 
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 with a mean of 0.37, ranging from -0.71 to 0.96.259 The correlation was higher in studies 
reporting results for males (r=0.47 on average) versus studies reporting results for females 
(r=0.36 on average), but with very similar ranges. In general, self-reported physical activity 
estimates were higher than those measured by directly methods.259 In overweight or obese 
individuals, self-reported physical activity was overestimated in all cases.259 Among 153 
adults aged 35-65 years, Ferrari et al.107 found that the accuracy of physical activity 
questionnaire measurements was higher for men than for women, for younger individuals and 
for those with lower BMI.  
 
One challenge in assessing physical activity is that women as a group spend more time on 
household and family activities than men. In surveys that did not include these activities, 
women tend to underestimate their activity level.7 In a review by Prince et al.259 some results 
suggest that patterns in the agreement between self-reports and direct measurements of 
physical activity may exist, but they are likely to differ depending on the direct methods used 
for comparison and gender. Differences between the self-report and direct measurements 
increase with the higher category levels of intensity.259 The fact that intensity is the least valid 
component assessed by self-reporting is supported by Sallis and Saelens who found that 
young people and adults overestimate their physical activity, particularly vigorous intensity 
activities.276 
 
Despite the advantages of using direct methods, these types of measurements are often 
expensive and time consuming resulting in difficulties in applying them to large populations. 
The direct methods also require specialized training and the physical proximity of the 
participant for data collection. 
 
Since resting metabolic rate and absolute energy cost during physical activity are increased in 
pregnant women,271,322 activity monitors must be validated in this specific population.330 To 
be able to give recommendations based on evidence, valid measurement tools are important.68 
One possible bias is that the activity monitors used have not been validated in the pregnant 
population. 
 
Validation studies quantifying the impact of measurement errors on physical activity 
estimates are essential to evaluate the impact of physical inactivity on health.107 The validity 
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 of activity monitors needs to be carefully examined in the actual research population.330 To 
my knowledge, few have evaluated activity monitors for use during pregnancy.68 Valid and 
reliable measurements of energy expenditure and physical activity are critical to understand 
the influence of physical activity on pregnancy outcomes.68  
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 In this thesis I will look into the influence of exercise during pregnancy on gestational 
diabetes and the two most common pregnancy-related muscelosceletal disorders; lumbopelvic 
pain and incontinence. 
 
Gestational diabetes 
 
Definition  
Gestational diabetes mellitus (GDM) is defined as carbohydrate intolerance with onset or first 
recognition during pregnancy210 and is usually diagnosed by an oral glucose tolerance test 
(OGTT), however, the OGTT procedure and the diagnostic criteria used vary.70 
 
 
Prevalence of GDM 
The prevalence of GDM has been reported up to 14 %.159 It has increased worldwide, 
however, there is variation in diagnostic criteria, ethnicity and the population studied.159,343 A 
prevalence of 5.6 % was found (unpublished data) in a cohort of a Scandinavian population in 
Oslo. This was in the “Stork” study conducted in 2002-2008 (N=1,032). In the “Stork 
Groruddalen” research program, conducted at the same time that included an urban 
Norwegian population (N=759), a prevalence of 13 % was found in gestational week 28 ± 
2.224 In 2009, 1.3 % of all pregnancies in Norway were registered as having GDM in the 
Medical Birth Registry of Norway.307 However, pregnant Norwegian women are not screened 
for GDM on a regular basis, and only women with identified risk factors are offered OGTT. 
Thus, the prevalence is probably underreported in the Medical Birth Registry of Norway, and 
the true prevalence is unknown. 
 
 
Risk factors for GDM 
The risk of diabetes in pregnancy reflects the underlying frequency of T2DM for a given 
population.168 Identified risk factors for GDM are obesity (BMI>30) diagnosed before 
pregnancy,314 ethnicity,168 polycystic ovarian syndrome,315 essential hypertension, 
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 hypertension in pregnancy,145 family history of diabetes in first-degree relatives and a history 
of GDM in previous pregnancy.1 In a population-based cohort study of 96,801 nulliparous 
pregnancies in the US, the proportion of women who developed GDM, consistently increased 
with increasing BMI. Both pre-pregnancy obesity and overweight were found to increase the 
risk of GDM.21 
 
 
Metabolic changes during pregnancy 
Pregnancy has been characterized as a diabetogenic event due to hormones with diabetogenic 
effects (estrogen, prolactin, human chorionic somatomammotropin, HPL, cortisol, and 
progesterone). The diabetogenic effects of these hormones lead to insulin resistance and 
increased insulin requirements.17 Insulin resistance is a physiological condition in which the 
natural hormone insulin becomes less effective in lowering blood sugars. The metabolic 
changes are in response to the increased demands of the rapidly growing fetus and placenta. 
By the third trimester, the maternal basal metabolic rate is increased by 10-20 % compared 
with that of the non-pregnant state.80 Among the nutrients crossing the placenta, glucose is 
quantitatively the most important, and is the primary energy source for feto-placental tissues. 
The glucose supply to the fetus is via passive glucose diffusion and therefore it is 
concentration dependent.142 
 
A normal pregnancy is characterized by mild fasting hypoglycemia, postprandial 
hyperglycemia, and hyperinsulinemia. This response is consistent with a pregnancy-induced 
state of peripheral insulin resistance, the purpose of which is likely to ensure a sustained 
postprandial supply of glucose to the fetus. Insulin sensitivity in late normal pregnancy is 50-
70 % lower than that of non-pregnant women.49 The mechanisms responsible for insulin 
resistance are not completely understood.80 
 
 
GDM and associated short- and long-term risk factors 
GDM is a risk factor for pregnancy complications,165,283 and is associated with short- and 
long-term morbidity in both the mother and the offspring.39,81,147,166,167 It is unclear if the 
complications are due to elevated glucose levels per se or by unidentified factors. In the case 
of maternal hyperglycemia and placental normal function, there will be increased placental 
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 transfer of glucose, fetal hyperglycemia develops and hyperinsulinism secondary to this 
alteration. As insulin is one of the main growth factors during fetal life, this hyperinsulinemia 
leads to macrosomia and to the complications secondary to the delivery of a large baby. Even 
minor degrees of hyperglycemia are associated with adverse outcomes. In the HAPO study, 
including 23,316 pregnant women who underwent a 75 g OGTT at 24-32 weeks of gestation, 
a strong continuous association was found between maternal glucose tolerance and a number 
of different adverse pregnancy outcome events even in the sub-diabetes range. There were 
positive associations between increasing levels of fasting, 1-hour, and 2-hour plasma glucose 
obtained by OGTT and birth weight above the 90th percentile, preterm delivery, shoulder 
dystocia, birth injury, intensive neonatal care, hyperbilirubinemia, and preeclampsia.211 
 
In the long term GDM is associated with risk factors for cardiovascular disease,180 and a 
higher risk of developing T2DM during the next 5-10 years for the mother.167 A meta-analysis 
found that women with GDM have at least a seven-fold increased risk of developing T2DM 
compared with those who had a normoglycaemic pregnancy (RR 7.43, 95 % CI 4.79-11.51).29 
And women developing GDM have a higher risk of the recurrence of GDM in the next 
pregnancy.166 Children born in GDM pregnancies have a higher risk of childhood obesity,147 
metabolic syndrome39 and T2DM as adolescents.81 In addition, children born in GDM 
pregnancies have a higher risk of developing GDM in their own pregnancy compared to 
children born to non-diabetic mothers.205 
 
Many of the risk factors for GDM and T2DM are the same (a family history of diabetes, 
raised BMI, increased age, and Asian and black origin) suggesting that the two disorders 
might have overlapping causes.29 
 
 
Exercise and glucose homeostasis 
In the non-pregnant state, physical activity improves glucose homeostasis through a direct or 
indirect impact on insulin sensitivity.15,41,88 Both aerobic and resistance training improve 
insulin sensitivity as shown by a reduction in the insulin response to a glucose load, and an 
improvement in peripheral insulin sensitivity. Muscle contractions stimulate glucose uptake in 
the complete absence of insulin. The effects of muscle contraction and insulin are additive, 
and the contraction and insulin stimulate glucose transport by separate pathways.140 However, 
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 exercise must be undertaken regularly to have beneficial effects.77,140 Both in prevention and 
treatment of T2DM, exercise plays an important role.77 A meta-analysis found that all types of 
exercise reduced the HbA1c levels in T2DM to a similar magnitude as those exerted by long-
term dietary, drug and insulin therapy.291 Therefore, regular sustained aerobic exercise in 
pregnant women may have the same effect and counteract the normal state of insulin 
resistance in late gestation. In the ACOG’s latest version from 2002 it is suggested that 
exercise has a possible role in the prevention and management of GDM.5  
 
Among non-pregnant women with T2DM, the intensity and duration of physical activity seem 
to be the most important factors that influence energy expenditure. However, there are 
conflicting results about whether the intensity or the volume of exercise is the most important 
determinant for the improvement of insulin action.139 Physical activity causes increased 
glucose uptake into active muscles balanced by hepatic glucose production, with a greater 
reliance on carbohydrate to fuel muscular activity as intensity increases. An increase in 
muscle mass from resistance training may contribute to blood glucose uptake from a mass 
effect.63 Combined strength and aerobic training is found to be superior to either type of 
exercise alone.291 In addition, the supervision of exercise sessions by qualified exercise 
trainers is found to be important for the best effect on blood glucose, and there should be no 
more than two consecutive days between bouts of aerobic activity.77 For those with T2DM, 
strength and aerobic training are recommended as well as initial instruction and periodic 
supervision by a qualified exercise trainer.77 
 
 
The role of exercise in prevention of GDM 
The effect of exercise on the development of gestational diabetes has been sparsely studied, 
and the study results are conflicting.23,59,151,313 In a systematic search on PubMed no previous 
RCT’s addressing the effect of physical activity in prevention of GDM in a general population 
of pregnant women were found (Table 2). Two recent trials assessed maternal glucose level 
and insulin sensitivity respectively with conflicting results. However, the study populations 
were small, only 84 and 83 subjects.23,151 Results from one meta-analysis demonstrate that 
greater total physical activity before or during early pregnancy is associated with a lower risk 
of GDM, with the magnitude of the association being stronger for pre-pregnancy physical 
activity.313 There is a lack of large RCTs that have a sufficient methodological quality to 
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 assess the effects of adequate regular exercise in pregnancy on glucose homeostasis.220 Two 
protocols for assessing exercise in the prevention of GDM in women at risk are 
published.69,243 A protocol for a Cochrane review on exercise for pregnant women in the 
prevention of GDM has recently been published.127 
 
The prevalence of GDM doubled from 1994 to 2002 in a multiethnic population in Colorado, 
US.82 The trend toward older maternal age, the epidemic of obesity and diabetes, and the 
decrease in physical activity and the adoption of modern lifestyles in developing countries 
may all contribute to an increase in the prevalence of GDM.106 Identifying ways that might 
help prevent GDM is a matter of urgent public health importance. 
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 Lumbopelvic pain 
 
History 
Historical evidence shows that pelvic girdle pain (PGP) in pregnancy was already known and 
recognized many centuries ago. Symphysis pubis dysfunction was mentioned by Hippocrates 
(ca. 400 BC) in his theory of “disjunction pelvica”.28 According to Hippocrates, the widening 
of the symphysis pubis only occurred during the first parturition, and then remained 
permanent and sufficient for later childbirths. The first to give a description of the clinical 
aspects of pelvic insufficiency in Norway was Skajaa, who in 1929 observed symptoms of 
pelvic insufficiency in 31 (16 %) of 185 patients from his private consultations.115 
 
 
Definition 
Pain is defined as an unpleasant sensory and emotional experience associated with actual or 
potential tissue damage, or described in terms of such damage.157 Pain is an individual and 
subjective experience that depends on a variety of biological, psychological and social 
factors.78 Low back pain (LBP) is usually defined as pain between the 12th rib and the gluteal 
fold, while PGP is defined as pain experienced between the posterior iliac crest and the 
gluteal fold, particularly in the vicinity of the sacroiliac joints. The pain may radiate in the 
posterior thigh and can also occur in conjunction with/or separately in the symphysis.326 
Although similar and overlapping mechanisms may be involved between PGP and LBP, some 
researchers argue that a distinction should be made.326 A clinical examination including pain 
provocation tests and/or tests of functional disturbances must be performed to distinguish 
between LBP and PGP,326 but the criteria are unclear. In this thesis the pain is referred to as 
lumbopelvic pain (LPP), no specific distinction is made between LBP and PGP except when 
this distinction is made in the references. 
 
 
Prevalence of LPP 
LPP during pregnancy is a common disorder. A review has reported an average prevalence of 
45 % with variations from 4-90 %.342 The variation is probably due to differences in study 
design and diagnostic procedures.326 Most of the literature use self-reports of LPP. It has been 
32
 shown that self-reporting generally reports 20 % higher prevalence than medical records, 
indicating that women in questionnaires report mild pain that normally would not come to the 
attention of the medical profession.342 In the MoBa study including 75,939 pregnancies, 58 % 
reported pain in one or more pelvic locations during pregnancy week 30, with 13 % reporting 
severe pain in one or more pelvic locations.34  
 
It has been stated that LPP is more common in the Scandinavian countries than the rest of the 
world.193 However, studies show that LPP is common in many 
countries,35,67,76,98,216,219,221,312,329 irrespective of the socio-economic status of the countries.35 
The majority of studies on LPP have been performed in the Scandinavian countries. One 
explanation for the assumed higher prevalence in Scandinavia may be that outside of 
Scandinavia pregnancy-related PGP is regarded as a normal pregnancy complaint rather than 
a syndrome.28  
 
 
Risk factors for LPP 
Identified risk factors with strong evidence are reported to be strenuous work, previous low 
back pain, previous LPP during or after pregnancy, and previous trauma to the pelvis.326,342  
 
It has been suggested that the hormone relaxin, which is known to remodel pelvic connective 
tissue in several mammalian species during pregnancy, plays an important role in the 
development of LPP. However, study results on the levels of relaxin and LPP are 
conflicting,10,178 and further research is needed to assess the possible role of relaxin and other 
pregnancy-related hormones in the development of LPP. Bjelland et al.33 found an inverse 
association between age at menarche and pelvic girdle syndrome (pain in all three pelvic 
joints) in the MoBa study, suggesting an association between hormonal factors and PGP. 
 
In the same cohort, Bjelland et al.34 found a positive relationship between parity and pain in 
all three pelvic locations, with a stronger association for severe pain. Other factors associated 
were previous LBP, emotional distress, BMI 30 kg/m2, physically demanding work, daily 
smoking, low maternal age and lower educational level.34 In another cohort (N=891), high 
BMI, low educational level, parity, previous LPP, a history of hypermobility and amenorrhea 
were factors influencing the risk of developing LPP.216 Albert et al.9 divided pregnant women 
33
 with PGP into five subgroups regarding pain location. They found different risk factors for 
the different subgroups, but common risk factors for all subgroups were a history of previous 
LBP, trauma of the back or pelvis, multiparity, high levels of stress, and job dissatisfaction. In 
a cross-sectional study including 283 pregnant women, Robinson et al.268 found that results 
from the Posterior Pelvic Pain Provocation test (P4) and Active Straight Leg Raise (ASLR) 
contributed independently to decreased physical ability in pregnancy week 30.  
 
LPP is considered to be a normal condition of pregnancy expected to spontaneously disappear 
after delivery.233 However, some women do not recover after birth. Albert et al.9 found a rapid 
decline in the number of diseased in the first three months after delivery, but after three 
months recovery was slow. Women classified with pelvic girdle syndrome had the worst 
prognosis, and those with symphysolysis had the best.9 The average prevalence of LPP 
postpartum is 25 %, with variations from 0.3 % to 67 %, and approximately 5 % report 
serious LPP.342 High age, early onset of symptoms in the pregnancy, severe pain at early 
gestation and low rate of weight retention postpartum are associated with persistent pain two 
years after pregnancy.312 High pain intensity during pregnancy indicated a poor prognosis 
after pregnancy.349 Women who have not recovered, have reduced quality of life compared to 
the general population.298,299 It has been suggested that poor coping strategies may be 
involved in the development of long-term pelvic pain postpartum.133 Olsson et al.242 found 
that pain catastrophizing and physical ability mid-pregnancy are predictors of postpartum 
LPP. Vøllestad and Stuge found that the ASLR test and belief in improvement were strong 
and independent predictors of clinical significance in women with PGP postpartum.328 
 
 
Influence of LPP on daily life 
LPP interferes with ordinary daily activities249 and reduces the quality of life.241 Considerable 
difficulties with activities such as housekeeping, walking, working and sexual life have been 
reported.134,214 Although the reported prevalence of LPP is more than 50 % in most 
studies,34,67,123,216,221,241,268,312,329 the majority of women are mild to moderately affected as 
shown by the average scores in pain and disability.67,266 
 
The median Disability Rating Index (DRI; an instrument for assessment of physical disability 
with scores in the range of 0-100) in a group of healthy women aged 30-39 years was <1.275 
34
 Olsson et al.240 found a median DRI score for pregnant women without LPP to be 10 and 27 
in women with LPP in mid-pregnancy. In late pregnancy the corresponding numbers were 24 
versus 54 in women without and with LPP,241 indicating more limited physical activity with 
advancing gestation. Higher DRI scores in women with LPP are also found in other 
studies.123,177,266 This suggests that pregnancy and LPP has an additive effect. Higher DRI in 
pregnant women without LPP than non-pregnant women underscores that even pregnancy in 
itself constitutes physical disability. 
 
Evidently, there is a wide range in the expression of the symptoms of LPP during pregnancy, 
and women are affected to various degrees.214 Some women experience pain in a very early 
stage of pregnancy, while others only experience pain in the final stage of pregnancy.266 In 
addition, some women have more restricted activities due to pain compared with other 
women. This suggests that other factors than hormonal and/or physiological changes might 
influence the prevalence of LPP during pregnancy. One recent study found that women with 
LPP in mid-pregnancy showed more pain catastrophizing and fear-avoidance beliefs than 
women without LPP.240 Of women with LPP during pregnancy, around 45 % have mild 
symptoms only; 25 % have severe pain; and 8 % are severely disabled.342 In a retrospective 
cohort study from Norway in 1998-99, 7 % of all women reported the use of crutches during 
pregnancy due to PGP.267 The localization and the nature of the pain vary. In pain research it 
is well known that there are large individual variations in pain ratings, even in patients with 
the same condition.231 The proportion of women with severe LPP in need of treatment has 
been shown to be close to 25 %.342  
 
 
Etiology, anatomy and function 
The etiology and pathophysiology of LPP is unknown. During pregnancy there are 
considerable changes in biomechanics and posture, when the center of gravity is moved 
anteriorly. Progressive lordosis is a characteristic feature of normal pregnancy. Compensating 
for the anterior position of the enlarging uterus, the lordosis shifts the center of gravity back 
over the lower extremities. This curvature and reinforcement of the lumbar vertebrae has 
evolved in humans to permit bipedal posture and locomotion despite up to a 31 % increase in 
the maternal abdominal mass by term.336 The anatomy and function of the pelvis is due to a 
combination of specific anatomic features (form closure) and the compression generated by 
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 muscles and ligament (force closure).327 This system prevents shear forces and is called the 
self-bracing mechanism290 (Figure 2). In 1992, Panjabi presented a model of the spinal system 
consisting of the passive, the active and the neural subsystems.246 The vertebrae, discs, and 
ligaments constitute the passive subsystem. All muscles and tendons surrounding the spinal 
column that can apply forces to the spinal column constitute the active subsystem. The nerves 
and central nervous system comprise the neural subsystem, which determines the 
requirements for spinal stability by monitoring the various transducer signals, and directs the 
active subsystem to provide the needed stability.246 Later Lee and Vleeming further developed 
this into a more integrated model of function of the lumbopelvic region. They used the terms 
form closure (passive subsystem), force closure (active subsystem), motor control (neural 
subsystem) and added emotion/awareness as a fourth component.183,184 The importance of the 
pelvic floor muscles (PFM) to increase the stiffness of the pelvic ring has been illustrated in a 
biomechanical study.256 During pregnancy the passive stiffness of the spine and the pelvis is 
likely reduced due to increased ligament laxity. In addition, the ability of some of the muscles 
to produce stabilizing force, particularly the abdominal muscles, may be compromised.97 
When the muscular capacity and the tension of the ligaments are inadequate, decreased 
compression across the sacroiliac joint will occur, insufficient stability will follow, and 
optimal load transfer between the back and legs will be comprised.257 
 
Figure 2. Form closure (a) and force closure (b) lead to a self-bracing mechanism (c). Printed 
with permission from C.J. Snijders©. 
 
New debates have arisen in the literature concerning the role of muscle function in LBP in the 
general population, and there is evidence of an association between reduced muscle function 
and the development of LPP in pregnant women.97 A pilot study suggests that pregnant 
women with gluteus medius weakness are 6 to 8 times more likely to have LBP than those 
without weakness.30 Gutke et al.124 found that women with LPP had muscle dysfunction in 
terms of lower levels of trunk muscle endurance and hip extension muscle strength as well as 
slower preferred gait speed compared with the women without LPP, both mid-pregnancy and 
36
 postpartum. Women with PGP had lower levels of back flexor endurance compared to women 
without LPP.124 In addition, Gutke et al.125 found that low endurance of back flexors, older 
age, combined pain in early pregnancy and work dissatisfaction were predictors of having 
persistent PGP or LPP three months postpartum. Sihvonen et al.289 found a relationship 
between LBP and muscle activity. They reported that the lower the back muscles activity 
during the first trimester of pregnancy, the greater the chances to experience LBP and 
disability throughout the pregnancy. De Groot et al.84 showed that pregnant women with LPP 
used more muscle activity, produced less force and scored higher on the ASLR compared to 
controls.  
 
The combined effect of the muscle dysfunction identified in these studies and the hormone-
induced increased ligament and joint capsule laxity in pregnancy, may increase the risk of 
insufficient force closure of the pelvis giving continuous strain on the pelvic ligaments and 
resulting in pain.257 Results from these studies strengthen the hypothesis that there is an 
association between muscle dysfunction and women who develop or have persistent LPP. 
However, it is not known if identifying women at risk in early pregnancy and offering them 
an intervention of strengthening adequate muscles, will prevent LPP. 
 
 
Sick leave 
In Norway, 59 % of pregnant women are on sick leave at least once during pregnancy with an 
average of 21.5 days off work.223 Comparable numbers for other countries may differ with 
type of social welfare system.304 LPP accounts for most of the sick leave among pregnant 
women in Scandinavian countries,121,223,305,350 causing a high impact in terms of loss of 
production and socio-economic costs. It has been demonstrated that women with postpartum 
PGP may have difficulties in returning to work.133 
 
 
Exercise 
Despite that women are encouraged to exercise during pregnancy, being pregnant seems to be 
an event that leads to reduced physical activity105,244 and women experiencing LPP are less 
likely to exercise regularly.244 A recent cross-sectional study showed that sedentary coping 
strategies were more frequent in women with LPP.67 This is supported by another study which 
37
 found that rest and relaxation were perceived as being significantly more important during 
pregnancy than regular exercise.75 
 
In the short term, resting and guarding may temporarily relieve pain. However, in the long run 
inactivity leads to deconditioning and weakening of muscles, which in turn predisposes a 
person to loss of function and pain. In the non-pregnant population there is general agreement 
that the best strategy in the treatment of chronic LBP seems to be encourage physical activity 
and exercise.8 A cross-cultural myth still suggests that pregnant women should be inactive 
and rest in order to protect the safety of the fetus.72 European guidelines326 and a Cochrane 
review249 clearly indicate the importance of both exercise and relaxation for pregnant women 
to enhance overall health and prevent pain during pregnancy. 
 
Besides being physically active maintain or improve fitness,208 observational studies have 
demonstrated that physical activity before pregnancy may reduce the risk of developing 
LPP.89,182,215 Also there is a reduced need for sick leave due to LPP.350 The explanation may 
be that women in good physical condition will probably handle the hormonal and 
biomechanical changes during pregnancy better. Another explanation may be that previous 
physical activity clearly is a determinant of actual physical status.215 
 
 
The influence of exercise on LPP 
There is a lack of RCT’s assessing the effects of physical activity to prevent or treat LPP in 
pregnant women. In a systematic literature search on PubMed (Table 3) only one RCT was 
found that assessed the preventive effect of exercise on LPP. The trial, including 301 
nulliparous women, assessed the effect of a 12-week intervention program with main focus on 
pelvic floor muscle exercises. At gestational week 36 the authors found a prevalence of self-
reported LPP of 44 % in the intervention group versus 56 % in the control group (p = 0.03). 
No difference was seen in sick leave due to LPP.228 Ten trials have assessed the role played 
by physical exercise on treatment of LPP. In general, seven out of ten trials found a positive 
effect from the intervention in the meaning of reduced pain intensity and/or improved 
functional ability compared to the control group.114,120,161,164,170,287,302 However, the trials are 
not comparable due to different interventions, length of intervention, intensity of intervention 
38
 and outcome measure. Four trials found reduced need for sick leave in the intervention 
group.120,164,234,350 
 
There is a lack of RCT’s assessing the effects of physical activity for pregnant women. Thus, 
both prevention and possible adverse effects on LPP and general disability as well as the 
effects on work related outcomes are sparsely studied.249  
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 Incontinence 
 
Definition 
Urinary incontinence (UI) is defined as “complaint of involuntary loss of urine”, while the 
term anal incontinence (AI) is defined as “complaint of involuntary loss of feces or flatus”.144 
AI can further be divided into fecal incontinence (FI; “complaint of involuntary loss of 
feces”) and flatal incontinence (“complaint of involuntary loss of flatus”).144  
 
 
Prevalence of UI 
UI is a common condition among women.213 In a Norwegian cohort study, EPINCONT 
(N=15,307), the overall prevalence of UI in nulliparous women were 10 %, and the 
prevalence increases with age.272 The prevalence of urinary leakage in pregnancy has been 
reported to vary between 9 % and 74 %.64,261 This variation is probably due to different study 
populations (various proportions of nulliparous/parous women), different definitions of 
incontinence (self-reports or standardized pad tests), different pregnancy lengths, and 
different definitions. The International Continence Society has changed the definition several 
times.3,4,144 In the first standardization of terminology of lower urinary tract function, UI was 
defined as “involuntary loss of urine which is objectively demonstrable and a social or 
hygienic problem”.3 As the definition changes, so will the prevalence estimate. Chaliha et 
al.64 (N=286) reported a prevalence of 9 % with genuine stress urinary incontinence (SUI) in 
gestational week 34 measured with urodynamics. Raza-Khan et al.261 (N=113) included 
women in the third trimester and registered any type of UI in a questionnaire and reported a 
prevalence of 74 %.  
 
In the MoBa study including 43,279 women from 1999-2006, 58 % of the women reported 
any UI and 35 % reported UI weekly or more in pregnancy week 30.334 The prevalence of UI 
increased from 26 % before pregnancy to 58 % in pregnancy week 30. The prevalence among 
nulliparous and parous women was 15 % and 35 % before pregnancy and 48 % and 67 % at 
30 weeks.334 A cohort of nulliparous women (N=1,128), who were continent before 
pregnancy, reported an UI incidence of 39 % at some point during pregnancy.292 Another 
observational study of primiparous women (N=1,501) found that 4 % reported UI before 
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 pregnancy and 38 % during pregnancy.187 In both studies the incidence of UI was low in the 
first trimester, rising rapidly in the second trimester and continued to rise more slowly in the 
third trimester.187,292 In a third cohort of nulliparous women (N=1,507), 11 % reported UI at 
least once per month before pregnancy, and the prevalence increased to 17 % in early 
gestation and 56 % in the third trimester of pregnancy.44 In all three studies the severity 
increased slightly with increasing gestation.44,187,292 A correlation between severity of UI and 
level of interference in daily living was found.292  
 
The increase in UI during pregnancy is mainly due to incidence of SUI.187,292 The prevalence 
of pure SUI is reported to be 1.7-8 times higher than the prevalence of pure urgency urinary 
incontinence (UUI) in pregnancy. Prevalence of mixed UI is reported to be 0.2-2.2 times of 
the prevalence of pure SUI in pregnancy.44,118,187,261 
 
In a systematic review including 33 studies on UI postpartum, a pooled prevalence of any UI 
postpartum was found to be 33 %, with weekly UI to be 12 % and daily UI 3 %.310 There 
were only small changes in the prevalence of UI over the first year postpartum.310  
 
 
Risk factors for UI 
Data suggest that pregnancy contributes to pelvic floor dysfunction later in life.194 The precise 
etiology of UI in pregnancy is unknown, but there is a variety of changes associated with 
pregnancy, e.g. hormonal and mechanical changes that could contribute.154 Prenatal 
physiological changes such as increases in intra-abdominal pressure of the growing uterus and 
fetal weight on the PFM throughout pregnancy together with pregnancy-related hormonal 
changes may lead to reduced strength and reduced supportive and sphincter functions of the 
PFM.148 
 
Incontinence during pregnancy has been linked to age,274 BMI,131 strenuous physical 
exercise,102 smoking history,131 and a family history of UI.292 In the EPINCONT study 
Rørtveit et al.274 found that women having their first baby after the age of 25 had higher 
prevalence of UI than women having their first baby before the age of 25 (28 % versus 23 %, 
p<0.01). However, the effect attenuated with increasing actual age, and it disappeared in the 
age group 50 to 64 years.274 
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 Developing de novo SUI during pregnancy was associated with BMI >30.187 In the MoBa 
study weight gain in pregnancy does not seem to be a clinically important risk factor for UI. 
However, weight loss postpartum may be important for regaining continence 6 months 
postpartum.333 Brown et al.44 found that women with subclinical urinary symptoms before 
pregnancy, younger women (18-24 years), older women (40 years), and those with a BMI 
30 were at an increased risk of developing de novo UI in pregnancy. The factor most 
strongly associated with the onset of UI during pregnancy was the presence of occasional 
leakage of urine before pregnancy.44 Solans-Domenech et al.292 found that the risk of UI 
increased in pregnant women >35 years, with overweight or obesity at baseline and a family 
history of UI. Hannestad et al.130 found that women were more likely to develop UI if their 
mother or older sisters were incontinent, suggesting that a genetic predisposition plays a role 
in the development of UI. 
 
Antenatal UI is found to be a risk factor for UI postpartum, and many authors have found that 
UI in pregnancy is an important predictor for UI later in life.48,91,110,155,286,319,324,332 A history 
of UI prior to pregnancy significantly increases the chance that postpartum UI will 
persist.104,294 In a cohort study it was found that most women experiencing postpartum UI had 
symptoms of UI during the third trimester.261 Another study found that five years after the 
first delivery, 33 % of women reported UI.323 In a twelve year prospective study, Viktrup et 
al.324 found that in women with onset of UI in pregnancy or shortly after their first delivery 
had increased risk of long-lasting symptoms. Among women who were continent during their 
first pregnancy and the postpartum period, the prevalence of UI 12 years after the first 
delivery was 33 % compared to 66 % in women who became incontinent during their first 
pregnancy and the postpartum period.325 
 
In the EPINCONT study including 27,936 women, the reported prevalence of any UI was 25 
% in the adult population, with the prevalence of incontinence increasing with age.132 In the 
Women’s Health Australia Project, including three age cohorts of women completed in 1996, 
women were asked if they had experienced leaking urine last year. The estimated prevalence 
of UI in young women (18-23 years, N=14,000) was 13 %, middle-aged women (45-50 years, 
N=13,738) 37 % and old women (70-75 years, N=12,417) 35 %.71 Middle-aged and older 
nulliparous women were almost three times more likely to report UI than nulliparous young 
women. UI was significantly associated with parity, constipation, obesity, past gynecological 
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 surgery and conditions which can impact on bladder control, such as coughing and sneezing 
on a regular basis.71 In twin studies it has been found that women (mean age 47 years) with at 
least two births are four times more likely to report UI than their nulliparous twin sisters.117 
Among premenopausal women, parous women have higher prevalence of UI than nulliparous 
women.273 Among postmenopausal women, a history of pregnancy and childbirth has little 
impact on the prevalence of UI. Old nulliparous women are as likely to have UI as parous 
women.43,273 It is assumed that  other factors, such a comorbid medical conditions and age-
related changes, outweigh the effect of previous pregnancies.235 The numbers of striated 
muscle fibers of the urethral sphincter decrease with age and parity, with an average loss of 2 
% per year from 15 to 80 years of age.19 In an epidemiological study it was found that 50 % 
of incontinence can be attributed to pregnancy and childbirth among parous women.248 
However, there are many unanswered questions, and the available literature cannot 
distinguish the effects of pregnancy from the effects of childbirth. 
 
High BMI and the presence of antenatal UI are modifiable risk factors. The presence of these 
risk factors may help clinicians target at-risk women for early intervention. 
 
 
Prevalence of AI 
In a review of 16 studies, the estimated prevalence of AI varied from 2-24 %, and the 
estimated prevalence of FI varied from 0.4-18 % in community-dwelling adults.195 AI is less 
studied in pregnancy, but the prevalence of AI has been found to increase from pre-pregnancy 
to late pregnancy.65,66,292 Prevalence rates for AI before, during, and after the first pregnancy 
of 0-1 %, 0-8 %, and 2-26 % have been reported.65,126,191,192,284,301,306,318,346 The presence of AI 
is mainly characterized by loss of flatus in more than 90 % of cases.292 
 
The prevalence of AI postpartum has been reported to be 9 % - 27 %.66,101,113,288,301 
 
 
Risk factors of AI 
Pregnancy and delivery are risk factors for AI in later life,47 and the first pregnancy and 
delivery is associated with a high prevalence of objective and subjective bowel dysfunction.66 
Age and excess weight gain during pregnancy are associated with the occurrence of AI during 
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 pregnancy,292 however, risk factors for development of AI during pregnancy have been 
sparsely studied. 
 
In twin studies, it has been found that women (mean age 47 years) with at least two births are 
three times more likely to report AI than their nulliparous twin sisters.2 Obstetric trauma is 
one of the major causes of AI in women. During delivery a sphincter trauma and/or pudendal 
neuropathy can occur. Risk factors for sphincter injury are vaginal birth, midline episiotomy, 
forceps delivery and vacuum-assisted delivery.101 A review including 18 studies found that 
symptoms of AI in the first year postpartum were associated with the mode of delivery.258 
Women with spontaneous delivery had increased risk of AI postpartum compared to cesarean 
delivery (OR 1.32, 95 % CI 1.04-1.68). In forceps deliveries, women had doubled risk of AI 
compared to cesarean delivery (OR 2.01, 95 % CI 1.47-2.74).258 Solans-Domenech et al.292 
identified AI during pregnancy and vaginal delivery as risk factors for AI postpartum. Women 
with FI de novo postpartum are more likely to have had a third or fourth degree anal sphincter 
rupture (OR 8.0, 95 % CI 4.6-13.8).318 A systematic review including 31 longitudinal studies 
found that third- or fourth-degree sphincter rupture was the only etiological factor strongly 
associated with postpartum AI.38 A meta-analysis included five studies with a total of 717 
women who underwent an endoanal ultrasonography to diagnose anal sphincter defects 
following a vaginal delivery.237 The study reports an incidence of 27 % anal sphincter defects 
in primiparous women and an incidence of 9 % new sphincter defects in multiparous women. 
Overall, 30 % of anal sphincter tears had symptoms, and 3 % of women experienced 
postpartum FI without anal sphincter defect.237  
 
 
Incontinence and quality of life 
In one prospective study (N=597), 42 % and 19 % reported SUI and UUI in gestational week 
36, of those only 6 % and 3 % reported it to be causing bother.320 Although UI is common, it 
reduces quality of life and affects social, physical, occupational and leisure activities.156  
 
AI is less prevalent than UI, but this condition is clearly a social and psychological burden 
with a significant impact on quality of life.108,129,150,189 FI further reduces quality of life in 
women with UI,108 and FI and UI together have a greater impact on quality of life than either 
condition alone.129 Women affected by moderate or severe FI may suffer embarrassment, 
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 social isolation, curtailed activities, and severely impaired quality of life.31 Despite the 
negative effect on quality of life, few women discuss AI with their medical providers.189 In a 
cohort study (N=906) women were asked about FI symptoms 10 months after birth, and 36 (4 
%) reported new FI after birth. In all,  27 (75 %) of 36 women had symptoms several times a 
week, however only five consulted a doctor.191 FI symptoms are known to be 
underreported.186,191 The reason may be embarrassment, but could also be little knowledge 
about treatment.  
 
 
Anatomy of the pelvic floor 
The pelvic floor (PF) is an important part of the continence mechanisms.19 The PF consists of 
several components between the pelvic peritoneum and the vulvar skin. These are (from 
above downwards) the peritoneum, viscera and endopelvic fascia, levator ani muscles, 
perineal membrane, and external genital muscles.86 The pelvic organs (vagina, bladder and 
rectum) are ensured by fascias and ligaments.  
 
The levator ani group of muscles (Figure 3A and 3B) keeps the urogenital hiatus closed.86 The 
different muscles have different fiber directions, and if each muscle could contract in 
isolation, they would all have different functions. However, the only known voluntary 
function of the PFM is a mass contraction best described as an inward lift and squeeze around 
the urethra, vagina and rectum.57 The levator ani muscles have constant activity, like that of 
other postural muscles.86 In addition, the PFM close the PF and carry the weight of the 
abdominal and pelvic organs, preventing constant strain on the ligaments.86 As long as the 
levator ani muscles function properly, the PF is closed and the ligaments and fascia are under 
no tension; the fasciae simply act to stabilize the organs in their position above the levator ani 
muscles. In continent women an automatic (unconscious) co-contraction occurs when 
abdominal pressure increases.50 The amount of striated muscle declines considerable with 
age251 and is associated with a decline in innervating nerves.245  
 
50
      
 
Figure 3A. Schematic view of the levator ani muscles from below after the vulvar structures 
and perineal membrane have been removed showing the arcus tendineus levator ani (ATLA); 
external anal sphincter (EAS); puboanal muscle (PAM); perineal body (PB) uniting the 2 ends 
of the puboperineal muscle (PPM); iliococcygeal muscle (ICM); puborectal muscle (PRM). 
Figure 3B. The levator ani muscle seen from above looking over the sacral promontory (SAC) 
showing the pubovaginal muscle (PVM). The urethra, vagina, and rectum have been 
transected just above the pelvic floor. PAM = puboanal muscle; ATLA = arcus tendineus 
levator ani; and ICM = iliococcygeal muscle. Printed with permission from John O.L. 
DeLancey©. 
 
The lower urinary tract is composed of the bladder and urethra. They form a functional unit 
and their interaction cannot be ignored. Each has two functions, the bladder to store urine and 
void, the urethra to control and convey.3 Urethral closure pressure must be greater than 
bladder pressure, both at rest and during increases in abdominal pressure to retain urine in the 
bladder.19 During activities, such as coughing, when bladder pressure increases several times 
higher than urethral pressure, a dynamic process increases urethral closure pressure to 
enhance urethral closure and maintain continence. This is referred to as “pressure 
transmission”. Both the magnitude of the resting pressure in the urethra and the increase in 
pressure generated during a cough determine the pressure at which a leakage of urine 
occurs.19 
 
Anal continence depends on several anatomic and physiologic entities such as the anal 
sphincter function, PF function, rectal distensibility, anorectal sensation, anorectal reflexes, 
A B 
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 intact nervous system, mental function, stool volume, stool consistency, and colonic transit. 
Deficiency in one or more of these factors can lead to AI.196 The anal sphincter muscles are 
located in the distal part of the anal canal. The anal sphincter involves the internal anal 
sphincter, external anal sphincter and puborectalis muscle.196  
 
In the non-pregnant women, the uterus is an almost solid structure weighing about 70 g and 
with a cavity of 10 ml or less. During pregnancy, the uterus is transformed to accommodate 
the fetus, placenta, and amnionic fluid. The total volume of the contents at term averages 
about 5 l, but may be up to 20 l or more. By the end of pregnancy, the uterus has achieved a 
capacity that is 500 to 1000 times greater than in the non-pregnant state.80 In late gestation, 
the fetal head markedly alters bladder geometry.90  
 
Pregnancy and delivery are associated with functional and anatomical changes in the muscles, 
nerves, and connective tissue of the PFM.128 In women with de novo SUI after their first birth, 
injury to the levator ani muscle is found twice as often as in women who are continent after 
delivery.87 The first vaginal delivery also results in changes in EMG patterns of striated 
sphincter musculature that is consistent with impaired muscular function persisting for at least 
six months beyond delivery.331 Deindl et al.85 compared parous women with SUI (n=8) and 
nulliparous continent women (n=10) with EMG-measures of the PFM. The muscle activation 
pattern was in principle similar except for lower holding time in a voluntary pelvic floor 
muscle contraction (VPFMC) and asymmetric and uncoordinated activity pattern in the 
levator ani muscles among parous incontinent women.85 Mørkved et al.227 (N=103) assessed 
muscle strength and thickness in nulliparous pregnant women at 20 weeks of gestation, and 
found higher maximal vaginal squeeze pressure and increment in muscle thickness in 
continent compared to incontinent women.  
 
 
Pelvic floor muscle training 
Pelvic floor muscle training (PFMT) for the treatment of UI was popularized by the American 
gynecologist Arnold Kegel in 1948.162 However, PFMT has been a part of exercise programs 
in Chinese Taoism for over 6000 years.99 PFMT has been found to have a high cure rate in the 
adult female population and is recommended as first line treatment for women with SUI, UUI 
or mixed incontinence.99 There are two hypothesis explaining the effect of PFMT; behavior 
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 modification and increased muscular strength. The rationale for teaching women how to 
perform a conscious contraction of the PFM before and during increases in abdominal 
pressure,212 is that the urethra and bladder base is prevented from descending.50 Miller et al.212 
found that 80 % of women with de novo SUI in pregnancy week 35 were able to reduce 
leakage during coughing by using the Knack maneuver (i.e. tighten the PFM in preparation 
for a known leakage-provoking event), with 55 % eliminating leakage completely. Neural 
adaptations can explain increases in muscle function before hypertrophy occurs. This effect is 
related to motor learning, since the more motor units that are recruited, the better will be 
muscle function.263 Strength training of the PFM builds up muscle volume, elevates the 
location of the PFM and pelvic organs, and closes the levator hiatus thus providing improved 
structural support for the PF as well as more optimal automatic function.51 Morphological 
changes such as increased muscle thickness (Figure 4), narrowed resting area of the levator 
hiatus, reduced puboviceral length and elevated resting position of the bladder and the rectal 
ampulla after PFMT have been documented after an intensive PFMT program.45 The 
functional changes (elevated resting position of the bladder and rectum and the reduced 
pubovisceral length and hiatus size at maximum Valsalva) may be explained by increased 
“stiffness” in the muscle-connective tissue complex.45 During pregnancy the growing uterus 
will compress the bladder. Strengthening the PFM results in better structural support for the 
bladder neck and a strong contraction of the PFM ensures continence during an abrupt 
increase in the abdominal pressure.50  
                
Figure 4. Illustration of an optimal (A) and non-optimal (B) pelvic floor muscle. 
(http://96.127.164.163/pelvic_muscles.html) 
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 The influence of PFMT on UI and AI 
A variety of hypotheses have been suggested about why PFMT might help prevent and treat 
incontinence in pregnancy and after delivery. A trained muscle might be less prone to injury, 
and previously trained muscles might be easier to retrain after damage as the appropriate 
motor patterns are already learned. It may be that previously trained muscle has a greater 
reserve of strength so that injury to the muscle itself, or its nerve supply, does not cause 
sufficient loss of muscle function to reach the threshold where reduced urethral pressure 
results in leakage.141 During pregnancy, training the PFM might help to counteract the 
increased intra-abdominal pressure caused by the growing fetus, the hormonally mediated 
reduction in urethral pressure, and the increased laxity of fascia and ligament in the pelvic 
area. A similar rationale might be used to support the use of PFMT to improve the function of 
the external anal sphincter and thus prevent AI.141 
 
In a systematic literature search on PubMed (Table 4) three previous trials were found 
addressing primary prevention of UI during pregnancy.119,200,262 Four trials included both 
continent and incontinent women in pregnancy.54,171,226,279 Three trials have assessed the 
effect of treatment of UI during pregnancy.92,282,340 No previously published trial addressing 
primary prevention of AI was found. One previous trial included PFMT in a general fitness 
program for pregnant women.54 This trial demonstrated that there was no difference in UI or 
AI between intervention and control groups. However, this trial had some limitations such as 
being underpowered, including no control of the women’s ability to perform a correct 
VPFMC, high dropout rates and low adherence to the exercise training protocol.54  
 
Common for all trials with a positive effect of PFMT are that they are based on thorough 
clinical assessment of the participants’ ability to contract the PFM correctly, had close follow-
up of the pregnant women either in groups or individually, and had high adherence to the 
exercise protocol. In contrast, trials with no effect had an inadequate training dosage, left the 
patients alone to train or had low adherence to the exercise protocol. As for all other strength 
training regimens, the effects of PFMT are dependent on the training dosage and adherence to 
training. Type of exercise, frequency, intensity and duration of the training in addition to the 
adherence to the exercise protocol will decide the effect size.55,136 The concept of intensive 
PFMT was introduced by Bø et al.55 The recommendations for effective strength training to 
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 increase muscle cross-sectional area and strength are 3 sets of 8-12 close to maximum 
contractions 3-4 times a week.136  
 
The success of training depends on the ability to effectively contract the PFM. It is estimated 
that 30 % of women are unable to contract the PFM on the first attempt.46,56 Bump et al.46 
found that only 49 % performed an ideal VPFMC after brief standardized verbal instruction, 
and Dinc et al.92 found that only 68 % of pregnant women were able to perform a correct 
VPMFC one week after individual thorough instruction. Vaginal palpation is most commonly 
used by physiotherapist to evaluate the function and strength of the PFM, however ultrasound 
is a more objective measure and is becoming an important clinical tool.58 
 
RCT’s have documented the effects of intensive PFMT and close follow-up of 
physiotherapists in the prevention and treatment of pregnancy-related UI.92,119,171,226,262,279,282 
A Cochrane review addressing the prevention of urinary- and fecal incontinence included 
mixed prevention and treatment trials.141 This review concluded that continent women 
randomized to intensive PFMT were 56 % less likely to report UI in late pregnancy and about 
30 % up to six months postpartum.141 Nevertheless, the Cochrane review and two other 
systematic reviews conclude that the effect of PFMT during pregnancy to prevent UI and AI 
is still open to question.42,141,225 The Cochrane review strongly recommends that all future 
trials of PFMT during pregnancy should collect data on AI, and highlights the need for large, 
pragmatic trials with population-based approaches, using intensive PFMT and recruiting 
antenatal women regardless of continence status or parity.141 There is a lack of trials 
investigating the effect of implementing PFMT in a more general training program for 
pregnant women. The cost of illness for incontinence is a substantial economic and human 
burden, highlighting the need for effective forms of management.213 The importance of 
effective prevention is obvious. 
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 AIMS OF THE THESIS 
 
A general aim of this thesis was to evaluate the efficacy of regular exercise during pregnancy 
in the prevention of pregnancy-related diseases and complications during labor.  
More specifically, the aims of the separate papers were: 
 
Study I 
To assess the efficacy of offering pregnant women a regular exercise program to prevent 
GDM and improve insulin resistance. 
 
Study II 
To assess if women randomized to a regular exercise program were more likely to report LPP 
than women receiving standard antenatal care. 
 
Study III 
To assess if pregnant women following a general exercise course including PFMT, were less 
likely to report UI and AI in late pregnancy than a group of women receiving standard 
antenatal care.  
 
Study IV 
To assess whether the energy expenditure recorded with the physical activity monitor 
SenseWearTM Pro2 Armband differs from that recorded with indirect calorimetry in pregnant 
women. 
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 MATERIAL AND METHODS 
 
Study design 
 
A two-armed, two-center RCT (Training in Pregnancy (TRIP) trial) of a 12-week regular 
exercise program was conducted and compared with standard antenatal care. Pre-tests were 
done at 18-22 weeks and post-tests at 32-36 weeks of pregnancy. 
 
Concealed randomization in blocks of 30 was performed at the Unit for Applied Clinical 
Research, Norwegian University of Science and Technology, by a web-based computerized 
procedure. The randomization was undertaken separately for each hospital to ensure that both 
sites would have approximately 50 % of their participants in each group. The staff involved 
with training or outcome assessments had no influence on the randomization procedure. 
Because of the nature of the study it was not blinded.  
 
 
Study population 
 
Studies I-III 
Pregnant women booking for routine ultrasound scan at St. Olavs Hospital, Trondheim 
University Hospital and Stavanger University Hospital were invited to participate in the trial. 
Women in Trondheim were recruited from April 2007 to June 2009, and women in Stavanger 
were recruited from October 2007 to January 2009. During the study period approximately 
12,000 women had a routine scan at the two hospitals. All women were invited with written 
information about the study attached to the invitation letter for the routine ultrasound scan.  
 
Women willing to participate were asked to contact the project coordinator. Inclusion criteria 
were Caucasian women aged 18 years with a singleton live fetus. Exclusion criteria were 
high-risk pregnancies and/or diseases that could interfere with participation (Appendix 1). For 
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 practical reasons we also excluded women who lived too far from the hospitals to attend 
weekly training groups (more than a 30 minute drive). Fewer than 10 % (N=875) of the 
approximately 12,000 women attending routine ultrasound scans at the two hospitals during 
the study period, were recruited into this trial. The two hospitals are serving large 
geographical catchment areas, and the numbers of women from eligible geographical areas 
were obviously lower than 12,000. The exact number of women who met all the inclusion 
criteria and were eligible for this study, is not known. 
 
Table 5. Comparison of women included in the TRIP trial with a sample of general pregnant 
population. 
 TRIP 
(N = 855) 
Sample of the 
general pregnant 
population 
(N = 177) 
P-value* 
Parity   0.69 
   0 57 % 59 %  
   1 30 % 27 %  
   2+ 14 % 14 %  
Pre-pregnancy weight – kg 65.8 ± 9.9 67.5 ± 14.1 0.14 
Pre-pregnancy BMI – kg/m2 23.1 ± 3.2 23.9 ± 4.8 0.04 
Booking weight – kg  70.6 ± 10.1 72.3 ± 13.9 0.14 
Booking BMI – kg/m2 24.8 ± 3.2 25.7 ± 4.9 0.03 
Exercised regularly pre-pregnancy  71 % 62 % 0.02 
Exercised regularly 3x/week at 
moderate to high intensity pre-
pregnancy 
32 % 32 % 0.85 
Exercise regularly at 18 weeks 52 % 49 % 0.50 
Exercise regularly 3x/week at 
moderate to high intensity at 18 
weeks 
13 % 20 % 0.01 
*Equal variances were not assumed in order to obtain a more conservative estimate between 
groups. 
Data are mean ± standard deviation or %. 
BMI denotes Body Mass Index. 
 
To assess whether the population in the TRIP trial was representative of the general 
population of pregnant women, all women attending a routine ultrasound scan at St. Olavs 
Hospital during a two month period in spring 2009, were asked to anonymously fill in a 
questionnaire covering baseline characteristics and levels of exercise (pre-pregnancy and at 
the time of the scan). Women were asked about the type, frequency and intensity of exercise. 
The questions were similar to those included in the main questionnaire of the trial. A total of 
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 177 women filled in the questionnaire and they were compared with women included in the 
TRIP trial (Table 5).  
 
Women included in the TRIP trial were also compared with women enrolled in the MoBa 
study232,244 and all births registered in the Medical Birth Registry in 2009229 (Table 6). 
 
Table 6. Comparison of women included in the TRIP trial with women included in the MoBa 
study and all births registered in the Medical Birth Registry in 2009. 
 TRIP 
(N = 855) 
MoBa 
(N = 73,579) 
Medical birth 
registry 
(N = 62,991) 
Age – years  30.4 ± 4.4 30.0 ± 4.6 29.7 ± 5.3 
Parity    
   0 57 % 43 % 43 % 
   1 30 % 36 % 35 % 
   2+ 14 % 21 % 22 % 
Marital status    
   Single 2 % 4 % 10 % 
   Married/cohabitant 98 % 96 % 90 % 
Booking BMI* – kg/m2 24.8 ± 3.2 25.2 ± 4.2 - 
Birth weight – g 3579 ± 540 3570 ± 611 3478 ±627 
Gestational age at birth – weeks 40.0 ± 1.8 39.3 ± 2.2 39.3 ± 2.3 
Exercised regularly 3x/week at 
moderate to high intensity pre-
pregnancy† 
32 % 46 % - 
Exercise regularly 3x/week at 
moderate to high intensity at 
inclusion*† 
13 % 28 % - 
*Women in the MoBa study filled in the questionnaire in gestational week 17 and women in 
the TRIP trial in gestational week 18-22. 
†Data from the MoBa study was based on 34,508 women enrolled in 2001-2005. 
Data are mean ± standard deviation or %. 
BMI denotes Body Mass Index. 
 
 
The MoBa study included 43.5 % of all eligible women.232 Since our results are comparable 
with the MoBa Study and the Medical Birth Registry, we find the external validity of the trial 
to be acceptable for Norway. However, the generalizability of the results should be interpreted 
with caution in other pregnant populations with higher BMI, less physically active women 
and in ethnically diverse populations.  
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 Study IV 
During a period of two months, women included in the RCT were also asked to participate in 
a study aiming to validate a physical activity monitor (SenseWearTM Pro2 Armband). Twenty-
nine pregnant women (24–43 years old) in the second (n=13) and third trimester (n=16) were 
recruited. None of the participating women used medications or smoked, which could have 
influenced the energy expenditure. 
 
 
Intervention  
 
Studies I-III 
Women in the intervention group were encouraged to exercise three days per week during the 
12-week intervention period. They received a standardized exercise program including 
aerobic activity, strength training and balance exercises. The training protocol followed 
recommendations from the ACOG and the Norwegian National Report on Physical Activity 
and Health.5,230 Training sessions of 60 minutes in groups of 8-15 women instructed by a 
physiotherapist were offered once a week over a period of 12 weeks (between 20 and 36 
pregnancy weeks). Each group session consisted of three parts: 
1) 30-35 minutes low impact aerobics (no running or jumping). Step length and body rotations 
were reduced to a minimum, and crossing of legs and sharp and sudden changes of position 
were avoided. The aerobic dance program was performed at moderate intensity, defined as 12 
and 14 on Borg’s rating scale of perceived exertion40 (Appendix 2).  
2) 20-25 minutes strength exercises using body weight as resistance, including exercises for 
the upper and lower limbs, back extensors, deep abdominal muscles and PFM. Three sets of 
ten repetitions of each exercise were performed. The PFMT was based on the one used by Bø 
et al.55 and repeated in the trial by Mørkved et al.226 
3) 5-10 minutes of light stretching, body awareness, breathing and relaxation exercises. 
In addition, women were encouraged to follow a written 45 minute home exercise program at 
least twice a week (30 minutes endurance training and 15 minutes strength and balance 
exercises) (Appendix 3). 
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 Women in the control group received standard antenatal care and the customary information 
given by their midwife or general practitioner. They were not discouraged from exercising on 
their own. Women in both groups received written recommendations on PFMT, diet and 
pregnancy related lumbopelvic pain. 
 
 
Methods 
 
Pre-tests were done at 18-22 weeks and post-tests at 32-36 weeks of pregnancy. The women 
met at the hospital for assessment. Height and weight were measured by an assessor. 
Frequency, intensity, duration and type of physical activity including PFMT were recorded 
for both groups in a questionnaire at inclusion and follow-up. In addition, women in the 
intervention group registered PFMT in a training diary. Adherence to the protocol was 
defined as exercising three days per week or more on moderate to high intensity. Performing 
the exercise program was strongly emphasized and recorded in the women's personal training 
diary and through reports from the physiotherapists leading the training groups. 
 
 
Study I – Assessment of GDM 
The primary outcomes of the RCT were the prevalence of GDM and insulin resistance 
estimated by the homeostasis model assessment method (HOMA-IR).202 HOMA-IR is an 
empirical mathematical formula based on fasting plasma glucose and fasting plasma insulin 
levels to calculate insulin resistance [(fasting plasma insulin (IU/mL) x fasting plasma 
glucose (mmol/L))/22.5]. All participants underwent a 75 g OGTT at inclusion (18-22 weeks) 
and at the end of the training period (32-36 weeks). Fasting and 2 hour glucose levels were 
measured in serum by the routine methods used by the hospital laboratory. GDM was 
diagnosed according to the WHO criteria as fasting glucose level in fasting whole blood 6.1 
mmol/L or plasma glucose 7.0 mmol/L, or 2 hour value 7.8 mmol/l.11 In addition, 
secondary outcomes, such as pregnancy complications and outcomes (e.g. newborn weight, 
gestational age, Apgar scores) were registered from the birth journal.  
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 Study II – Assessment of LPP 
Possible effects of regular exercise during pregnancy on LPP were one of six other pre-
specified outcomes. LPP and sick leave due to LPP were measured on self-reports. The 
prevalence estimate of LPP was based on a simple question: “Do you have pain in the pelvic 
and/or lumbar area?” (Yes/No).  
 
Secondary outcomes were disability, pain intensity and fear-avoidance beliefs. Disability was 
measured by The Disability Rating Index (DRI) containing 12 questions concerning physical 
function, of which each question is scored on a 100 mm visual analog scale from “no 
disability” to “totally unable”.275 The DRI index is calculated as the mean of 12 questions. 
Since pain intensity varies throughout the day,209 the women were asked about worst pain in 
the morning and the evening on Visual Analog Scales (VAS 0-100 mm). The modified Fear-
Avoidance Beliefs Questionnaire (mFABQ) consists of four of the five items from the fear-
avoidance beliefs about physical activity.188 Ratings were made on 0 to 6 point scale ranging 
from strongly disagree to strongly agree. Scores may range from 0 to 24 with high scores 
showing stronger fear-avoidance beliefs.  
 
 
Study III – Assessment of incontinence 
Possible effects of regular exercise during pregnancy on incontinence were another of the six 
pre-specified outcomes. UI was measured by self-reports using a severity index.280,281 Women 
were asked to report their urinary leakage when A) coughing / sneezing / laughing, B) when 
being physically active (running or jumping), C) when sudden changes in position / lifting or 
D) leakage accompanied by a strong urgency to void. Answer alternatives were “Yes” or “No. 
Urinary leakage was subclassified according to the definitions given in the standardized 
terminology of lower urinary tract symptoms.144 Women confirming any type of urinary 
leakage (alternative A, B, C or D) were referred to as having UI. Women confirming loss of 
urine in association with alternatives A, B or C were defined as having SUI, while women 
confirming loss of urine with alternative D were defined as having UUI, The outcome 
measures of UI were further divided into two severity categories with respect to frequency, 
“urinary leakage < once per week” or “urinary leakage  once per week (severe UI)”. 
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 AI was registered as FI and flatal incontinence during the previous four weeks based on one 
question from the St. Marks score.317 Women reporting leakage of solid and/or liquid stool 
during the last four weeks were categorized as fecal incontinent, and women reporting flatus 
during the last four weeks were categorized as flatal incontinent.  
 
 
Study IV – Assessment of energy expenditure 
Energy expenditure was measured with SenseWearTM Pro2 Armband (BodyMedia Inc., 
Pittsburgh, PA, USA), an activity monitor including a two-axis accelerometer, a heat flux 
sensor, a galvanic skin response sensor, a skin temperature sensor and a near-body ambient 
temperature sensor, which collects minute-by-minute data with up to 14 days memory store. 
The SenseWearTM Pro2 Armband was attached to the right arm over the triceps brachii muscle 
at the mid-point between the acromion and olecranon processes, in accordance with the 
manufacturer’s instructions (Figure 5A). Data from the monitor were downloaded with 
software developed by the manufacturer (SenseWear Professional Research Software version 
6.1; BodyMedia Inc.).  
 
Oxygen consumption (VO2) was measured using a portable oxygen analyzer with mixing 
chamber (MetaMax II, CORTEX Biophysik MetaMax® II portable CPX system; Cortex 
Biophysic, Leipzig, Germany). The analyzer was validated against the Douglas bag technique 
in five non-pregnant individuals during walking and running on a treadmill. The analyses 
showed 10–15 % overestimation of oxygen consumption measured by MetaMax II. 
Calibration was conducted before each test period. Expired gases were collected via a 
breathing mask (Figure 5B). A gas calibration of the O2 and CO2 analyzers, volume 
calibration of the volume transducer and calibration of the pressure analyzer were performed 
before all tests, in accordance with the manufacturer’s instructions. Data were analyzed with 
Metasoft v1.1 (Cortex Biophysic). 
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Figure 5. The SenseWearTM Pro2 Armband attached to the right arm (A) and the MetaMax II 
breathing mask (B). 
 
Both devices were synchronized with a digital clock prior to measurement. The portable 
oxygen analyzer and the breathing mask were attached to the woman and the measurement 
started. The measurement period lasted for approximately 90 minutes during daytime, and 
various physical activities were performed by the participating women. All started with 15 
minutes of sedentary behavior, sitting on a chair reading magazines. Thereafter, nine women 
performed 60 minutes of calisthenics (rhythmic aerobic exercise with stretching, strength and 
co-ordination exercises to music) in a group setting led by an instructor. They ended their 
exercise period with 15 minutes cycling on a bicycle ergometer. Another 20 women 
performed 30 minutes brisk walking outdoors followed by 10 minutes relaxing in a sitting 
posture, 15 minutes cycling on a bicycle ergometer and then 20 minutes calisthenics, all led 
by an instructor. The intensity of activities was not limited. The test leader was on site, 
supervising the activities. The type and estimated length of activities were registered by the 
test leader during the measurement period. Data from the direct measurements of VO2 and 
SenseWearTM Pro2 Armband were transferred to Microsoft Excel® and synchronized for 
further analysis. All data were computed at one minute intervals. The VO2 data were 
transformed into kilojoules per minute by multiplying VO2 in liters per minute by a factor of 
20.15.203 
A B 
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 Ethics  
The procedures followed were in accordance with ethical standards of research and the 
Helsinki declaration.309 The women received written (Appendix 4) and oral information, and 
they signed informed consent forms. The participants were not compensated financially. The 
study was approved by the Regional Committee for Medical and Health Research Ethics 
(REK 4.2007.81) and registered with Clinical trial gov (NCT 00476567). 
 
 
Power calculations 
 
Studies I-III 
For the principal power calculation of the trial we assumed a GDM prevalence of 9 % in the 
control group and a prevalence of 4 % in the intervention group (risk difference of 5 %). 
Under these assumptions a two-sample comparison (Chi squared) with a 5 % level of 
significance and power of 0.80 gave a study population of 381 patients in each group. This 
sample size was able to detect a 0.2 SD difference on continuous variables (insulin resistance) 
given the same power and significance level. Assuming a 10 % dropout rate we needed to 
include about 880 pregnant women. 
 
 
Study IV 
Sample size calculation was based on a standard deviation of 5 and 7 kJ (per min) with a 
significance level of 0.05 and power of 0.80. We needed 24 subjects to detect a mean 
difference of 5 kJ between indirect calorimetry and SenseWearTM Pro2 Armband.  
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 Statistical analyses 
 
Study I 
The primary data analysis was according to the “intention–to-treat” principle using Stata 
software version 10.0 for Windows (Stata Corporation, College Station, Texas). A two sample 
test of proportions for univariable analyses was used for complete case analysis of continuous 
variables and a simple linear regression was used for univariable analysis and analysis of 
covariance when adjusting for baseline values. The estimated risk differences were 
accompanied with 95 % confidence intervals (CI) and corresponding p-values. A mixed 
model with random slopes was used to assess the potential impact from missing data. This 
model used the interaction between the treatment group and time to estimate the baseline 
adjusted differences between the exercise and control groups. Exploratory analyses using the 
same statistical models were performed to compare women in the intervention group who 
adhered to the protocol with the total control group.  
 
 
Studies II-III 
The data were analyzed according to the “intention–to-treat” principle using binary logistic 
regression for dichotomous variables and ANCOVA for continuous variables. The results 
were presented as crude and baseline adjusted estimates with 95 % CI. The statistical analyses 
were performed with SPSS® (Statistical Package for Social Sciences, version 19 for 
Windows; SPSS Inc., Chicago, USA). 
 
 
Study IV 
A Bland-Altman plot was constructed to demonstrate the relation between the differences 
(SenseWearTM Pro2 Armband minus indirect calorimetry) and the average values of the two 
methods for recording energy expenditure during the measurement period. The mean 
differences and limits of agreement were calculated according to Bland and Altman.36 A two-
way mixed, single-measure, parametric intraclass correlation [ICC (3,1)] was performed for 
evaluating the extent of agreement between SenseWearTM Pro2 Armband and indirect 
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 calorimetry. Analyses were conducted in SPSS® (Statistical Package for Social Sciences, 
version 15 for Windows; SPSS Inc., Chicago, USA). 
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 RESULTS 
In all, 875 women consented to participate in the trial. Twenty women were excluded or 
withdrew before the first examination: thirteen did not meet the inclusion criteria, five 
miscarried and two had twin pregnancies. A total of 855 women were randomly allocated to 
an intervention group or a control group (Figure 6). However, 33 women in the intervention- 
and 61 in the control group were lost to follow-up. Data from 396 intervention group women 
and 365 control group women were included in studies II and III. In addition, 21 intervention 
group women and 38 control group women failed to complete the OGTT. Data from 375 
intervention group women and 327 control group women were included in a complete case 
analysis in Study I. 
        
Figure 6. Flow of study participants. 
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 Group characteristics 
The groups had similar baseline characteristics (Table 7). Adherence to protocol (exercising 
three days per week or more at moderate to high intensity) in the intervention group was 55 
%. For comparison 10 % in the control group exercised three days per week or more at 
moderate to high intensity at follow-up (p<0.001). In the intervention group, 72 % exercised 
at least once per week compared to 30 % in the control group (p<0.001). In the intervention 
period, women in the intervention group exercised 2.0 (95 % CI 1.9-2. 2) days per week on 
moderate to high intensity compared to 0.7 (95 % CI 0.6-0.8) in the control group (p<0.001). 
There was no difference between groups in weight gain, weight and BMI at follow-up (Table 
7). No serious adverse events related to physical exercise were seen, and the outcomes of 
pregnancy were similar in the two groups. 
 
Table 7. Maternal characteristics at baseline and follow-up. 
 Intervention group 
(N = 429) 
Control group 
(N = 426) 
 
p-value 
At inclusion (pregnancy week 18-22):  
   Age – years  30.5 ± 4.4 30.4 ± 4.3 0.70 
   Parity   0.71 
      0 247 (58) 239 (56)  
      1 125 (29) 129 (30)  
      2+ 57 (13) 58 (14)  
   Weight – kg  70.4 ± 9.8 70.8 ± 10.3 0.51 
   BMI – kg/m2 24.7 ± 3.0 25.0 ± 3.4 0.14 
At follow-up (pregnancy week 32-36):  
   Weight – kg  77.2 ± 10.0 77.6 ± 10.4 0.60 
   Weight gain – kg  7.0 ± 2.4 7.2 ± 2.6 0.17 
   BMI – kg/m2 27.1 ± 3.1 27.4 ± 3.4 0.15 
Data are mean ± standard deviation or n (%). 
BMI denotes Body Mass Index. 
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 Main results 
The results are described in detail in each of the papers, hence only a summary of the main 
results is given here. 
 
 
Study I – GDM  
No differences were found in the prevalence of GDM between groups; 25/375 (7 %, 95 % CI 
4.3-9.7) intervention group women compared to 18/327 (6 %, 95 % CI 3.3-8.6) control group 
women (p=0.52). Complete case analysis demonstrated lower fasting insulin and insulin 
resistance in the intervention group compared to the control group at follow-up, but when 
adjusting for baseline values the differences were reduced. To evaluate the potential effects of  
attrition and missing data, a linear mixed effects model was applied for all included subjects, 
N=855. The results were similar (lower fasting insulin and insulin resistance in the 
intervention group), but the differences were halved when adjusting for baseline values. 
 
 
Study II – LPP  
There were no differences in the percentage of women reporting LPP in the two groups after 
the 12 weeks intervention period. However, the proportion of women on sick leave due to 
LPP and the odds ratio (OR) were lower in the intervention group (p=0.01). When adjusting 
for baseline sick leave due to LPP, the estimated OR was still significantly lower (p=0.04). 
No differences were found between groups regarding disability, pain intensity or fear-
avoidance beliefs both unadjusted and adjusted for baseline values of the outcome measure.  
 
 
Study III – Incontinence  
After the intervention period, significantly less women in the intervention group reported UI 
and SUI. The findings were consistent when adjusting for baseline values. A lower proportion 
of women in the intervention group (3 %) than the control group (5 %) reported FI, however, 
the difference was not statistically significant.  
 
75
 Subgroup analyses were done based on groups stratified according to urinary continence 
status at inclusion. Sixty-nine percent of the continent women and 40 % of the incontinent 
women were nulliparous. The subgroup analyses showed that women in the intervention 
group who were continent for urine at inclusion, reported significantly less severe SUI (once 
per week) and UUI (p=0.03 and p=0.006) after the intervention period. Furthermore, among 
women who were incontinent for urine at inclusion, the proportion reporting UI, UI once per 
week and SUI after the intervention period was lowest in the intervention group (p=0.002, 
p=0.03 and p=0.007). The findings were consistent when adjusting for baseline values. 
Subgroup analyses on groups stratified according to anal continence status at inclusion 
showed no significant difference. 
 
In the intervention group, 95 % reported weekly PFMT at 32-36 weeks of gestation compared 
to 79 % in the control group (p<0.001). The proportion of intervention group women 
performing PFMT three times per week or more was 67 % compared to 40 % in the control 
group (p<0.01).  
 
 
Study IV – Energy expenditure 
A total of 29 women were included in the validation study. Thirteen women were in the 
second trimester and 16  in the third trimester. Twenty women carried out conditioning 
exercises such as brisk walking, running or bicycling in addition to strength exercises, 
whereas nine participated in calisthenics and rhythmic aerobic exercise. The mean period with 
energy expenditure recordings was 85 minutes (range 80–89). 
 
Mean total energy expenditure during the period with free-living activities was 1,618 kJ (95 
% CI 1,492–1,744) for indirect calorimetry and 1,482 kJ (95 % CI 1,364–1,600) for 
SenseWearTM Pro2 Armband. When comparing energy expenditure during free-living 
activities, the mean difference and limit of agreement from the Bland–Altman plot was í136 
± 343 kJ. SenseWearTM Pro2 Armband underestimated energy expenditure by 9 %.  
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 DISCUSSION 
The central aspects in each of the studies have been discussed in the respective papers. Here I 
will concentrate on some methodological aspects and address the main issues across the 
studies. 
 
To my knowledge this is the largest RCT assessing exercise during pregnancy in the 
prevention and treatment of pregnancy-related conditions. Healthy pregnant women were 
included. Women in the intervention group were offered a 12-week exercise program, 
including PFMT, to be performed three times per week in the second half of pregnancy. A 
total of 55 % of intervention group women exercised three times per week in late pregnancy, 
compared to 10 % in the control group. At follow-up, there was no difference between groups 
in the prevalence of GDM or level of insulin resistance. The prevalence of LPP in both groups 
was similar, however, less women in the intervention group were on sick leave due to LPP. 
The intervention group reported less UI in late gestation, and this group had both a primary 
and secondary prevention effect. A physical activity monitor was validated and found to be a 
valid instrument in pregnant women. The TRIP trial was a two-armed, two-centered 
randomized controlled trial with concealed randomization. However, there are some 
limitations. 
 
 
Methodological aspects 
 
Design 
RCT is considered to be the gold standard design when assessing the effects of treatment, 
providing the most reliable evidence on the efficacy of healthcare interventions.217 Proper 
randomization reduces selection bias at trial entry, balancing both known and unknown 
factors. The intervention group was offered a regular exercise program. The control group 
women received no intervention, but were not advised against exercising on their own. The 
optimal study design would be to have a control group free from exercise. However, it would 
be unethical to stop control group women exercising on their own, and adding a control group 
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 of sedentary pregnant women would ruin the randomized design. Including only sedentary 
women with no previous habit of regular exercise in the trial would have been another option. 
 
Blinding is considered an important methodological factor to ensure high internal validity of a 
RCT. In the TRIP trial the investigator was aware of group allocation. Addition of a blinded 
assessor would increase the costs and thus was difficult for practical reasons. However, 
analysis of blood glucose and insulin was done blinded to group allocation, and prevalence of 
LPP and incontinence were based on self-reports minimizing the effect of bias due to the non-
blinded study design. 
 
The possibility of recall bias is minimal in the TRIP trial, since women were asked to report 
LPP and incontinence at present, except for AI in which women were asked to recall 
symptoms last four weeks. 
 
It is possible that women in the intervention group were «eager to please» because they were 
offered a free exercise class. Thus, they may have reported fewer symptoms than they actually 
experienced. On the other hand, the exercise program exposed women attending the 
intervention group to a variety of situations that trigger incontinence and challenges the local 
and global spinal stabilizing muscles. This means that the effects of the training program may 
be underestimated regarding incontinence and LPP. 
 
 
Study population 
Another limitation to be considered is selection bias. Less than 10 % of all women attending a 
routine ultrasound scan in the study period assigned for the trial (875/12,000). To be able to 
attend, women should be Caucasian, healthy with low risk pregnancies and live within 30 
minutes drive from the hospital. The actual number of women meeting the inclusion criteria is 
not known. The women volunteering for the trial contacted the project coordinator after 
receiving a written invitation, and were mainly well motivated to exercise during pregnancy. 
Women in the TRIP trial might therefore be a selected group of women already in good 
physical condition. 
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 Women included in the TRIP trial were from an urban area in Norway. When compared with 
a general population of pregnant women in Trondheim, women in the MoBa study and the 
Medical Birth Registry, the external validity was found to be acceptable for Norwegian 
pregnant women regarding age, parity, BMI, exercising habits, gestational age at birth and 
birth weight (Table 5 and 6). However, in the MoBa study the youngest women (<25 years), 
those living alone, mothers with >2 previous births, previous stillbirths and smokers were 
strongly under-represented compared with the total population pregnant women in Norway in 
the same time period.232 
 
The intervention was based on both group training and individual training. This may have 
caused practical difficulties for some of the invited women (childcare, work, transport). We 
have not been able to assess the characteristics of non-participants. However, women in the 
TRIP trial were healthy Caucasian women with mean BMI within the normal range. 
Therefore, the results from our trial should be interpreted with caution in groups with less 
physical activity, higher BMI and other ethnicities.  
 
 
Intervention  
The intervention was based on the current recommendations for the general population 
(exercising three times per week including both aerobic and strength training). Healthy 
pregnant women are encouraged to follow the same exercise recommendations as non-
pregnant. The exercise program required no equipment, all strength exercises were performed 
with own body weight as resistance. The women chose according to their own preferences 
what type of endurance training to perform when doing the home exercise program. The 
strength and balance exercises were similar to those performed in the group sessions. All 
strength exercises were shown in three different positions reflecting various degrees of 
difficulty.  The weekly group sessions were led by skilled physiotherapists, who followed a 
standardized exercise program. Supervision of exercises is critically important in improving 
quality of exercise performance. The supervision by a qualified professional and proper 
prescription of the program variables have been found to be important for effective resistance 
training.175 In addition, a strong correlation between the quality of exercise performance and 
decrease in pain in non-pregnant patients with neck pain and LBP has been found.112 The 
exercise program also included information on related topics such as incontinence, LPP, 
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 ergonomics, exercise in pregnancy and the postpartum period. Most of the exercise groups 
were visited by a gynecologist who informed about exercise in pregnancy, contractions, and 
answered questions from the women. 
 
The control group received standard care and written information about LPP, PFMT and diet. 
The brochure on PFMT included a detailed evidence-based PFMT program similar to the 
PFMT program included in the intervention. A high percentage of women in the control group 
reported performing PFMT. In spite of this, the intervention group demonstrated significantly 
less UI than the control group women. However, women in the control group were not 
instructed in correct VPFMC at enrolment in the trial. Since it is well known that many 
women do not perform a VPFMC correctly after only verbal or written information,46,56 there 
is a possibility that some women in the control group performed the contractions incorrectly. 
Other important issues are thorough instructions and motivation. Women in the intervention 
group had weekly instructions and practical training in groups led by skilled physiotherapists. 
 
The two examinations during the study period were done at the hospital, and all women 
diagnosed with GDM were referred to standard follow-up of diabetes nurses and 
endocrinologists. If other problems were discovered, women were referred to a midwife or 
gynecologist. Both examinations were in addition to standard antenatal care. 
 
The 12-week intervention period was during the second half of pregnancy. There were several 
reasons for this approach. First, the study invitation was attached to an invitation to a routine 
ultrasound scan. Thus, we were able to invite all eligible pregnant women in the catchment 
areas. Second, all women had ultrasound before inclusion, and we were assured that only 
women with one single fetus and a low risk pregnancy were included. And third, at study start 
there were some discussions between experts regarding leisure time physical activity and the 
risk of early miscarriage.197 However, in the light of our findings and previous research, I 
believe that promoting health of women of reproductive age before conception and helping 
women to have a healthy and active lifestyle during pregnancy are the most promising 
approaches in preventing pregnancy-related conditions such as GDM, LPP and incontinence.  
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 Compliance 
Compliance is essential for proper interpretation of the effect of an exercise intervention. In 
this trial only 55 % managed to follow the exercise protocol. Reported reasons for not 
following the protocol were mostly attributable to pregnancy symptoms, child care and work 
commitments. Exercising three times per week can be hard to achieve for a pregnant women 
taking into account family- and work commitments and a body in continuous change.  Two- 
thirds of the exercise protocol was exercises to be performed home. From a public health 
perspective strategies to increase adherence to exercise must be of importance. This might be 
through public health information campaigns, information about health benefits of regular 
exercise given by a physiotherapist during antenatal care, offering free exercise courses 
during pregnancy and that the employer offers time for exercise included in working hours. It 
is important to emphasize that health benefits of regular exercise is not only limited to 
maternal profits, but is most likely to influence the fetus and protect against overweight, 
metabolic syndrome, diabetes and other cardiovascular diseases in the adolescents and 
adulthood.  
 
 
Withdrawals and loss to follow-up 
Loss to follow-up after recruitment and attrition affects the generalizability of the results. Any 
loss to follow-up decreases internal validity, but differential rates of loss to follow-up among 
comparison groups cause major damage.285 In general, less than 5 % loss to follow-up in RCT 
is  acceptable, whereas greater than 20 % loss to follow-up will potentially imply serious 
threats to validity.285 In the TRIP trial we experienced 11 % loss to follow-up on self-reported 
outcomes and 18 % on OGTT. The respective percentages in intervention and control groups 
were 8 % vs. 14 % on self-reports and 13 % vs. 23 % on OGTT. These differences were 
considered acceptable. One reason for loss of data at the OGTT was that performing the 
OGTT caused nausea in some women who therefore did not complete the test. In addition, the 
tests were performed in daytime due to the need of an overnight fast, and lasted for almost 
three hours including OGTT, questionnaires and physical tests. This may have been difficult 
for some women due to work commitments. 
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 Statistics and power calculations 
All participants were included in the analysis in the groups to which they were originally 
assigned (“intention-to-treat” analysis). The intention-to-treat principle underlies the primary 
analysis in an RCT to avoid bias associated with non-random loss of participants.181 Since 
only 55 % adhered to the exercise protocol it is difficult to conclude on the direct effect of the 
exercise protocol on glucose metabolism, LPP and incontinence. Explorative analysis can be 
performed on the protocol adherents. However, such analysis has some limitations since they 
are based on only a subset of the subjects initially included in the trial. The results may be 
explained by other confounding variables and results should therefore be interpreted with 
caution. 
 
When the present trial was planned no prevalence studies on GDM from Norway were 
published. The power calculation of the trial was based on previous international studies 
reporting prevalence up to 14 %. Since the TRIP trial was a population-based approach and 
invited all women irrespective of risk factors, a prevalence of 9 % was chosen and a reduction 
to 4 % in the intervention group was assumed. The overall GDM prevalence in the TRIP trial 
was 6.1 % at 32-36 weeks of pregnancy indicating that the study was slightly underpowered. 
However, even with a larger trial, there would probably be no statistically significant 
difference in GDM prevalence between groups (7 % vs. 6 % in the present trial). This is 
supported by our secondary outcome, 120 minutes OGTT, which was not different between 
the groups. Being a continuous variable, this outcome has considerably more power. With a 
sample size of 440 in each arm, we had a power of 87 % to detect a difference in 120 minutes 
OGTT of 0.25 mmol/L based on a t-test for two independent samples given a common SD of 
1.2 in the groups and a 2-tailed alpha of 0.050. 
 
The prevalence of AI in late pregnancy was found to be 5 % vs. 3 % in the present trial. AI is 
less prevalent during pregnancy than UI, and the trial was underpowered to demonstrate any 
possibly difference between groups as shown by the wide confidence intervals. 
 
Despite the randomized design some of the baseline characteristics were significantly 
different between groups at inclusion. This was accounted for in the statistical analysis. 
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 Outcome measurements 
Physical activity and exercise 
Physical activity is a complex action characterized of its intensity, duration, frequency and 
type of activity.218 The level of physical activity in the TRIP trial was assessed with self-
reports which have some limitations. The questions regarding exercise (frequency, intensity 
and duration) were taken from the Pregnancy Physical Activity Questionnaire (PPAQ). 
Intensity is found to be the least valid component assessed by questionnaires.276 It has been 
shown that much of a women’s moderate-intensity activity is performed in unstructured 
settings, and that activities are performed for short periods and are intermixed with light-, 
moderate-, and sometimes vigorous-intensity activities.201 The challenge with self-reports is 
to capture all type of activities. In general, adults are recommended to engage in regular 
exercise and increase the level of daily physical activity (Figure 7). It might be that not only 
the amount of weekly exercise, but the levels of daily energy expenditure (related to the 
women’s occupation, housework, child and family care, leisure activities and exercise) in sum 
are the most important aspects for disease prevention. A physical activity monitor would 
provide a more objective answer to the weekly level of exercise and daily total energy 
expenditure. However, the physical activity monitor needs to be validated for the actual 
population studied. The SenseWearTM Pro2 Armband was found to be a valid objective 
physical activity monitor, but due to lack of time and resources we were not able to use this 
device on all women in the TRIP trial. 
 
 
Figure 7. The physical activity 
pyramid  
(http://irishcancer.ie/preventio
n/physically_active.php) 
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 Gestational diabetes 
Fasting and 2-hour glucose levels were measured in serum by the routine methods used by the 
hospital laboratory the same day as taken. The level of insulin was measured in serum after 
being stored in a freezer (-80 °C). GDM was diagnosed according to the WHO criteria 
(fasting glucose level in fasting whole blood 6.1 mmol/L, or plasma glucose 7.0 mmol/L, 
or 2-hour value 7.8 mmol/L).11 Comparison between different studies can be difficult 
because the OGTT procedure and diagnostic criteria vary.70 We chose to use HOMA-IR as a 
measure of insulin sensitivity, but HOMA-IR may not be the most sensitive way of assessing 
the impact of exercise on insulin resistance. HOMA-IR is regarded as a good measure of 
overall insulin resistance in pregnancy, but it may provide a better reflection of liver rather 
than peripheral insulin resistance.169 Exercise most likely exerts its effect peripherally by 
reducing peripheral muscle insulin resistance.59  
 
 
Lumbopelvic pain 
The prevalence estimate of LPP was based on self-reports, and was not verified with clinical 
tests. Some authors argue that it is important to distinguish between LBP and PGP,326 but this 
was not done because it was not within the scope of this thesis to classify pain into different 
types, or according to location. It has been argued that because back pain is a subjective 
phenomenon, self-report is the most appropriate method of measuring this outcome.173 
However, different definitions of back pain may result in different estimates of prevalence 
and incidence, and no single definition has been generally accepted in back pain research, 
making comparison between studies difficult. We did not ask the women whether they had 
LPP before the present pregnancy or if the onset of pain were during the present pregnancy. 
Thus, we do not know if we were dealing with old recurrent pain or a new pain. Östgaard et 
al.348 have shown that more than one in five (22 %) women had ongoing back pain before 
getting pregnant. We assume that this may be true for a number of women included in the 
TRIP trial, and this was another reason why the term “pregnancy-related” was not used 
together with “lumbopelvic pain”. 
 
The DRI reflects function and disability rather than pain. It was primarily developed for non-
pregnant with LBP, but has been used on a wide range of musculoskeletal problems. DRI 
surveys the difficulties in performing specific activities. Hence it is the degree of difficulty 
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 that is assessed. The DRI is not optimal for pregnant women since activities such as “lifting 
heavy objects” and “running” are included. When the TRIP trial was initiated, no pregnancy-
related instrument for physical ability was found. Later, the Pregnancy Mobility Index321 and 
the pelvic girdle questionnaire297 were developed. The Pregnancy Mobility Index321 evaluates 
functioning in relation to back and pelvic pain in the following three main areas: daily 
mobility in the house, household activities and mobility outdoors.  The pelvic girdle 
questionnaire297 is a condition-specific instrument for assessing activity limitations in women 
with PGP during pregnancy and postpartum. 
 
Pain is multidimensional and the respondents communicate far more than just intensity about 
their pain.339 The reliability and validity of measuring pain intensity by VAS have been 
discussed.303 Pain intensity measured by VAS is a subjective phenomenon quantifying the 
pain. The repeatability of VAS has been found to be good.339 The VAS used for rating pain 
intensity in LBP showed good reliability over 24 hours,265 and the VAS also showed 
sufficient reliability when used in acute pain.32 A number of studies have demonstrated that 
pathology does not correlate well with pain, importantly, the absence of identifiable pathology 
does not mean the absence of pain.339  
 
Fear-avoidance refers to the avoidance of specific movements or activities based on fear of 
pain or (re)injury. The mFABQ is a modified version of the original FABQ, and consists of 
four of the originally five questions regarding general physical activity. The mFABQ was 
chosen since it is found that even subjects without pain can answer these questions.188   
 
Both DRI and VAS are continuous variables and intend to provide more graded information 
on LPP than merely the presence or absence of LPP. The DRI and VAS has previously been 
used in pregnant and postpartum women assessing LPP,228,240,269,299 thus allows for 
comparison between studies which is considered important. This was the main reason for 
choosing DRI and VAS as outcome measures. 
 
 
Incontinence 
Both UI and AI were measured by self-reports. The severity index280,281 and the St. Marks 
score317 are validated and reflect the frequency and amount of leakage and have been used in 
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 numerous studies in different populations. The question of UI is in accordance with the 
International continence society’s present definition of UI symptoms; “any complaint of 
involuntary leakage of urine”.144 In the TRIP trial we wanted to cause minimal discomfort to 
healthy pregnant women and therefore did not perform any quantification of the amount of 
urine lost with standardized bladder volume. However, Haylen et al.144 emphasize that to 
diagnose “urodynamic stress incontinence” the correlation between a woman’s symptom, 
sign, and urodynamic investigations should be included 
 
The relationship among different severity measures of UI in women with predominantly SUI 
has been found to be weak to moderate, and they appear to measure different aspects of the 
incontinence condition.12 Thus, the different severity measures are not interchangeable when 
characterizing a patient population or assessing outcomes. To facilitate comparison between 
studies a standardized measurement tool should be agreed upon.  
 
AI was measured with the St. Marks score which covers frequency, severity, urgency, pad use 
and social restrictions.317 The St. Marks score is a widely used severity score, ranging from 0 
(complete continence) to 24 (complete incontinence). In the TRIP trial only the first question 
regarding frequency was used (“have you experienced leakage of solid stool / liquid stool / 
gas last four weeks”). Women answering rarely / sometimes / weekly / daily were categorized 
as having AI. 
 
AI during pregnancy is less prevalent than UI and therefore prone to type II error, i.e. the trial 
was too small to detect any possible clinical differences between groups. 
 
Both the severity index and the St. Marks score are validated and reliable measurement tools 
widely used in previous research, and therefore chosen for this trial.  
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 Main results 
 
Study I – GDM 
No previous RCT’s have assessed the effect of regular exercise in the prevention of GDM in a 
general population of pregnant women. However, two smaller trials have assessed the effect 
on insulin resistance.23,151 The present results on insulin resistance are in accordance with the 
results from Hopkins et al.151 Adherence to the exercise protocol in the TRIP trial was 55 % 
vs. 75 % in the trial by Hopkins et al.151 Both trials included women with low risk of GDM, 
the interventions lasted for 12 weeks and started mid-pregnancy. In contrast, Barakat et al.23 
included pregnant women at 6-9 weeks of gestation and women were encouraged to exercise 
three times per week throughout pregnancy. The adherence to the exercise protocol was 85 %. 
In gestational week 24-28 the glucose levels were lower in the intervention group compared 
to the control group. However, that trial had some limitations; glucose levels at baseline were 
not measured, the glucose screening test was done non-fasting and there was no control of the 
level of physical activity in the control group. Clapp et al.73 assessed whether increasing or 
decreasing levels of exercise mid-pregnancy altered fetal growth. The results suggested that 
fetoplacental adaptations are dependent on the period of gestation in which exercise training is 
initiated and maintained, as well as the intensity or volume of exercise performed.73 
 
A small study of five healthy nulliparous women, who underwent a 100 g OGTT 30 min 
following a 30 min exercise bout on 50 % of maximal aerobic capacity in the third trimester, 
and a similar OGTT on a day without prior exercise, found no differences in the plasma 
glucose response between the control and exercise conditions. Plasma insulin levels were 
lower after exercise (23 % lower, p<0.05) indicating an increase in peripheral insulin 
sensitivity.344  
 
In non-pregnant women, the acute effect of exercise includes increased glucose uptake in 
skeletal muscle via an insulin-independent mechanism that bypasses the insulin signaling 
defects associated with insulin resistance.140 The effects of one single exercise session on 
insulin sensitivity persist up to 48 hours. Individuals who undertake regular training, may 
change the expression or activity of a variety of signaling proteins involved in the regulation 
of skeletal muscle glucose uptake,347 and pre-pregnancy physical activity has been 
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 consistently associated with a reduced risk of GDM.313 Oken et al.239 found that vigorous 
physical activity before pregnancy and continuation of activity into early pregnancy may 
reduce a woman’s risk for developing abnormal glucose tolerance and GDM. During 
pregnancy, an increase in insulin resistance occurs secondary to the diabetogenic effect of one 
or more of the gestational hormones secreted by the placenta.17 The marked reduction in 
maternal insulin sensitivity in late pregnancy increases the glucose supply to the fetus.61 The 
results from Hopkins et al.,151 Barakat et al.,23 and the TRIP trial suggest that in a normal 
healthy pregnancy, maternal insulin sensitivity is regulated persistently to achieve optimal 
fetal growth and is not sensitive to the chronic training adaptations in late pregnancy as 
previously described in non-pregnant individuals.152 The findings support the safety of 
maternal exercise for fetal well-being. Thus, there is a possibility that regular exercise before 
pregnancy and in early pregnancy is more important than exercise during the second half of 
pregnancy, since chronic changes in the regulation of skeletal muscle glucose uptake are 
adapted, and women may be better to handle the metabolic stress of a pregnancy. 
 
In the literature there is agreement that exercise must be undertaken regularly to have 
beneficial effect, but there is conflicting evidence whether the intensity or volume of exercise 
is the most important determinant for improvement of insulin action in the non-pregnant.139 In 
addition, there are unanswered questions regarding gestational endocrine changes and glucose 
homeostasis in general, and insulin-stimulated glucose uptake in particular. It is well known 
that exercise has an important role both in the prevention and treatment of T2DM. Even 
though T2DM and GDM seem to have overlapping causes, it might be that other mechanisms 
influence glucose metabolism in GDM than in T2DM. Since only 55 % of the intervention 
group women adhered strictly to the exercise protocol, we cannot conclude if exercising at 
least three times per week may influence glucose metabolism. If exercise training has an 
effect on improving peripheral insulin sensitivity in pregnant women, the differences between 
groups in levels of exercise may have been too small to show any differences. In addition, the 
intensity of the exercise program was instructed to be moderate (12-14 on Borg’s scale) 
according to the recommendations.5 Intensity of activity may have been too low. There is 
some indication that vigorous-intensity activities may have greater benefit for reducing 
cardiovascular disease and premature mortality than moderate-intensity physical activity.137 
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 Controversy still exists about the screening and diagnosis of GDM. In the majority of GDM-
cases, carbohydrate intolerance is asymptomatic and can only be detected by routine 
screening challenge tests. The prevalence of GDM among women without risk factors is low. 
In the Medical Birth Registry of Norway, 1.3 % of all pregnancies in 2009 were diagnosed 
with GDM.307 In a Scandinavian population in Oslo in 2002-2008, the STORK study, a 
prevalence of 5.6 % was found, and in the TRIP trial 6.1 % was diagnosed with GDM. In the 
TRIP trial 10 % of the population had a pre-pregnancy BMI >27 kg/m2 which according to 
current guidelines in Norway is one criteria of screening for GDM. It is questionable whether 
the selective screening procedure in Norway captures all women with GDM. 
 
 
Study II – LPP 
The result on reduced need of sick leave due to LPP in the intervention group was in 
accordance with three previous trials.120,164,234,350 The intervention in the TRIP trial was from 
a public health perspective; including women from a general population rather than women 
with LPP. In Norway, 59 % of pregnant women are on sick leave at least once during 
pregnancy with an average of 21.5 days off from work,223 and LPP accounts for the majority 
of sick leave among pregnant women.121,223,305,350 Sick leave represents considerable 
implications for public health costs and productivity. In 1999, SINTEF Unimed reported that 
each day on sick leave on average constitutes NOK 1700 in costs for the employer.146 Days on 
sick leave were not counted in the TRIP trial, but it is likely that total days on sick leave were 
lower in the intervention group, because of the lower percentage on sick leave (22 % vs. 31 
%). Myklebø and Thune reported that the number of pregnant women on sick leave increases 
with increasing gestation,223 and Myklebø reported that several healthy pregnant women are 
sick listed because the work is too demanding or exhausting.222 
 
An interesting question is whether the difference in sick leave in the TRIP trial was caused by 
more frequent exercise in the intervention group or simply by closer follow-up. Being 
physically active maintain or improve fitness,208 and a recent RCT has shown that exercising 
women had an increased perception of health status.25 In the TRIP trial skilled 
physiotherapists with knowledge about pregnancy and exercise during pregnancy were 
leading the exercise groups. In addition, intervention group women knew that they would be 
referred to a midwife or a gynecologist if adverse pregnancy-related conditions occurred. In a 
89
 qualitative study of 19 Australian women, receiving advice regarding exercise from health 
professionals and receiving reassurance that their pregnancy progressed satisfactorily were 
two of the motivating factors that facilitated women’s engagement in physical activity.72 The 
weekly group training was also an opportunity to get social support by other pregnant women. 
Being with other pregnant women is found to be another motivating factor for physical 
activity during pregnancy.72 
 
The TRIP trial included 855 healthy pregnant women and less than 10 % of the eligible 
women signed up for the trial. It is possible that women with pronounced early onset LPP did 
not sign up for this study. However, nearly 60 % of the participants reported experiencing 
LPP at the time of inclusion, though mildly affected. The generalizability of the study results 
may not be extended to women with severe LPP. No differentiation between LBP and PGP 
was done in this study, and we are therefore not able to conclude whether the results on sick 
leave are representative for women with PGP or LBP only. 
 
To our knowledge only one RCT has studied the preventive effect of exercise on LPP. The 
trial found a reduction of LPP in the intervention group, but no difference in sick leave due to 
LPP.228 That study included only nulliparous women, and the intervention was less intensive 
with PFMT as main focus. The intervention program in the TRIP trial focused on general 
fitness and strength. It was designed for pregnant women, but not specifically for women with 
severe LPP. The weekly group training sessions had only few possibilities of individual 
adjustments. Research has found that exercise focusing on activation of deep local muscles 
promoting motor control and stability is superior to general strength exercises in women with 
PGP.298,299 In addition, individualization of the treatment is found necessary.298,299 At 
inclusion 60 % reported LPP. However, the TRIP trial was not a treatment trial. If the aim of 
the trial had been to treat LPP the intervention program would have been different. Despite 
the importance of motor control, muscular strength is still considered a fundamental physical 
element necessary for health, functional ability, and enhanced quality of life.174 No women 
with LPP, regardless of group allocation, received treatment of the physiotherapists involved 
in the trial, but were advised to contact a physiotherapist and/or their general practitioner. 
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 Study III – Incontinence 
Previous trials have documented the effect of intensive PFMT during pregnancy in prevention 
and treatment of UI,92,119,171,226,262,279,282 but the TRIP trial is the first to document a prevention 
and treatment effect of PFMT when implemented in a general exercise program for pregnant 
women. The role of PFMT in prevention and treatment of AI in pregnancy has been sparsely 
studied, and one Cochrane review strongly recommends that all future trials on PFMT in 
antenatal and postnatal women collect data on AI.141 The TRIP trial was unfortunately 
underpowered to detect any possible differences in AI between groups. Nevertheless, the 
TRIP trial is the largest RCT at present assessing prevention and treatment of AI. 
 
General strength training programs for all striated muscles demonstrate an increase in strength 
due to neurological and morphological factors.111 The present trial did neither assess strength 
nor neurological changes after PFMT. In a previous trial including nulliparous women, 
Mørkved et al.226 found reduced prevalence of UI and increased PFM strength in the 
intervention group following a 12 week PFMT program. Studies have found that an increase 
in strength is found after few weeks of strength training, and the increase in strength continues 
at least 12 months after starting strength training.111 The rapid rise in strength at the start of a 
training program is primarily due to neurological adaptations such as increased motor-unit 
recruitment and firing frequency.111 In MRI-studies an increase in muscle thickness is found 
after 8-12 weeks, with a plateau after 6 months.111 During pregnancy the continence 
mechanism is continuously challenged due to the increased weight of the fetoplacental unit. In 
addition, the TRIP trial included both nulli- and multipara women. Multipara women may 
have damage to the pelvic floor from previous births. If the intervention period in the TRIP 
trial had been prolonged, muscle hypertrophy would in theory increase and the prevalence of 
UI in the intervention group may have been further reduced. 
 
The PFMT followed standard strength training principles and should be performed three days 
per week. However, in some rehabilitation situations maximum contraction, or overload, is 
not possible and more frequent training sessions need to be used and are often more 
desirable.93 Women in the intervention group with existing UI were therefore encouraged to 
perform PFMT more frequently than three days per week, most preferable daily. 
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 In spite of the favorable result from previous trials in preventing and treating UI during 
pregnancy, one study198 casts doubt on whether the success rate reported in previous trials can 
be achieved in the “real world”. Mason et al.198 examined the instruction in PFMT given to 
women during pregnancy or following delivery, to assess the quality of any instruction 
provided, and to consider these in the light of the women’s view of the service. They found 
that the routine instructions in PFMT during pregnancy or following childbirth were provided 
on an ad hoc basis. They concluded that there is need for the service to be reorganized so that 
all women receive high-quality instruction during pregnancy, with a reminder to exercise 
following birth. It has also been suggested that in order to maximize compliance with PFMT, 
it may be advisable to concentrate on providing women with more information about UI and 
developing techniques that help women to remember to perform exercises.95 Another trial by 
Mason et al.199 aimed to investigate whether women who experienced UI following childbirth 
were provided with information on the condition or whether they seek help and what help 
they received. The majority (69 %) had not received any information about UI either during 
pregnancy or following birth. Most women thought that information about UI should be 
provided during pregnancy to be warned that the condition could occur at this time and 
following birth.  
 
Comparison of prevalence estimates between studies is difficult because of methodological 
aspects. However, the trial by Mørkved et al.226 was performed in the same geographical area 
10 years ago and classified women with or without UI with the same outcome measures and 
at the same gestational age as the TRIP trial. The prevalence of UI was halved in the TRIP 
trial compared to the previous trial. In recent years following the trial by Mørkved et al.226 
there has been an increased awareness on PFMT both among health professionals and 
pregnant women which may have resulted in lower prevalence of UI among pregnant women. 
The studies from Mason et al.198,199 were performed more than 10 years ago, and the 
awareness of PFMT may have changed. 
 
A large proportion of women in the control group reported doing regular PFMT during the 
intervention period. Still, the intervention group demonstrated significantly less UI in late 
pregnancy. This underscores that for PFMT to be effective, thorough instruction in VPFMC, 
intensive PFMT and close follow-up is necessary.  
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 Women being physically active are more frequently exposed to higher and more repetitive 
increases in abdominal pressure compared to more sedentary women. The prevalence of SUI 
in young nulliparous elite athletes is high,52,236 and morphologic and functional differences in 
elite athletes has been found.179 A myth still persists among birth attendants that strong PFM 
may obstruct labor. In contrast, Salvesen and Mørkved found that women following a PFMT 
program during pregnancy reduced the length of the second stage of labor significantly 
compared to a control group,278 and other studies have found no negative effect of PFMT on 
labor.6,53 
 
 
General discussion 
The current guidelines 
There is international consensus about the importance of exercise during pregnancy, and 
guidelines for exercise during pregnancy and the postpartum period are worked out by the 
ACOG,5 the Society of Obstetricians and Gyaecologists of Canada Clinical Practice 
Obstetrics Committee and Canadian Society for Exercise Physiology Board of Directors,83 
Sports Medicine Australia,293 The Royal College of Obstetricians and Gynaecologists,308 and 
the Norwegian National Council on Nutrition and Physical Activity.230 The ACOG states that 
“In the absence of either medical or obstetric complications, 30 minutes or more of moderate 
exercise a day on most, if not all, days of the week is recommended for pregnant women.”5 
 
The ACOG guidelines were based on the recommendations for adults presented in 1995.247 In 
2007, the ACSM and the American Heart Association issued an updated version of the 1995 
recommendations on physical activity in the adult population with the intent to provide a 
more comprehensive and explicit public health recommendation for adults based upon 
available evidence of the health benefits of physical activity.137 The recommendations 
included both aerobic and strength training.137  
 
Since ACOG’s latest version in 2002 new science has emerged that has enhanced our 
understanding of the amount of physical-activity expenditure needed and the intensity of 
exercise needed to improve health outcomes and quality of life in adults, and this has been 
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 taken into account in the new recommendations for adults.137 Today, pregnant women are 
recommended to exercise with moderate intensity, and an upper level of safe exercise 
intensity has not been established. Salvesen et al.277 found that exercise at intensity above 90 
% of maximal maternal heart rate in pregnant elite athletes may compromise fetal wellbeing.  
 
It is now almost a decade since the new guidelines on exercise during pregnancy were 
published, and in this period an increasing amount of evidence has been published suggesting 
that the recommendations are too conservative. However, the optimal dose of recreational 
physical activity (i.e. total volume of energy expenditure and specific frequency, duration and 
intensity) for pregnant women remains to be determined.68 
 
There are only few RCT’s assessing the role of exercise in pregnancy, and those published 
have involved small numbers of predominantly lean, physically active participants. 
Furthermore, most of the studies have provided minimal quantification of exercise 
performance.176 Future trials should aim at including sedentary and/or overweight women. 
The determination of the optimal dose of physical activity for pregnant women has been 
hampered by the complexity of assessing physical activity in general. Valid and reliable 
measurements of activity are critical to understand the influence of physical activity on 
pregnancy-related outcomes. Today, several physical activity monitors are available and will 
provide further knowledge about exercise in pregnancy. However, it is of importance that the 
validity of activity monitors need to be carefully examined in the actual research 
population.330 It is unknown whether a dose-response or a threshold of physical activity in 
pregnancy exists, which would be of major importance for public health policy.68 
 
Barakat et al.24 found that supervised, light intensity resistance exercise training performed 
during the second and third trimester of pregnancy does not have a negative impact on the 
newborn’s body size. There is evidence that improved muscular strength has beneficial effects 
in the prevention of chronic diseases as well as in the ability to cope with daily living 
activities in both healthy and diseased people.300,341 Other potential benefits of resistance 
training include better posture and independence. The British308 and Australian guidelines293 
on exercise during pregnancy include strength training in accordance with the exercise 
recommendations for adults.  Zavorsky and Longo345 have recently highlighted that there is a 
need for an updated version of the exercise guidelines in pregnancy into a more concise 
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 format for pregnant women and health professionals. They suggest that specific definition of 
moderate-intensity exercise or the recommended amount of weekly physical-activity energy 
expenditure together with light strength training should be included in the guidelines.345 
 
 
Exercise training in antenatal care 
Exercise during pregnancy is recommended for healthy pregnant women, but exercise classes 
are not included in standard antenatal care. It is important that the interventions found 
effective in RCT’s with high methodological quality, are implemented in the ante- and 
postnatal health care system. The TRIP trial aimed to assess the effect of the recommended 
levels of exercise. Even though the TRIP trial failed to prove any preventive effect on GDM, 
the result on reduced sick leave due to LPP and less UI are important findings. In addition, no 
serious adverse events related to exercise were seen. Providing accurate information and 
encouraging pregnant women to engage in healthy behavior during pregnancy is a necessary 
first step toward improving maternal and child care.60 Each pregnancy is a unique opportunity 
to educate. Offering women high standard antenatal classes led by skilled physiotherapists 
should be given priority. In Norway antenatal care is free of charge, and offering exercise 
classes as part of standard care would eliminate any differences for all social groups. 
Providing physical activity information to all pregnant women can help reduce disparities in 
physical activity knowledge and may increase positive attitudes towards physical activity.60  
 
During pregnancy and after delivery significant changes take place in the body. Studies have 
shown that many women experience ill health following pregnancy and childbirth. According 
to Glazener et al.116, as many as 17 of 20 women developed health problems of some kind, 
whilst Blomquist and Söderman37 found that only 6 % of women had no problems (were 
asymptomatic) four months after delivery. Common health problems postpartum include UI 
and FI, depression, haemorrhoids, constipation, breast and perineal pain, dyspareunia, 
headaches, backache and exhaustion.199 Physiotherapists are trained in pre- and postnatal care, 
and postgraduate courses are given all over the world. Thus, physiotherapists should be part 
of a multidisciplinary team in hospitals, maternity care centers and health care centers. The 
physiotherapist should promote health of the pregnant and postpartum women and on the 
motor development of the child. Additionally, this service should offer treatment of problems 
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 that women experience in this period, to prevent these problems from being intolerable in 
later life. 
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 CONCLUSIONS 
Study I 
There was no evidence that offering women a 12-week standard exercise program during the 
second half of pregnancy prevents GDM or improves insulin resistance in healthy pregnant 
women with normal BMI. 
 
Study II 
Women offered a 12-week exercise program during second half of pregnancy report LPP as 
frequently as women in the control group. However, regular exercise reduced the need for 
sick leave due to LPP. This supports the general advice that pregnant women should be 
encouraged to exercise during pregnancy. 
 
Study III 
Women offered a 12-week exercise program including PFMT reported less UI than control 
group women. The results document that pregnant women should be advised to do PFMT to 
prevent and treat UI. Thorough instruction in correct PFM contraction and PFMT is 
important, and specific PFM exercises should be included in exercise classes for pregnant 
women. The preventive effect of PFMT on AI should be further explored in future trials. 
 
Study IV  
The study showed that SenseWearTM Pro2 Armband provides a valid measure of energy 
expenditure during pregnancy. The instrument is feasible to use both in research and in a 
clinical setting. 
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 IMPLICATIONS FOR FUTURE RESEARCH 
 
Based on the present findings there is a need for further research during pregnancy: 
x to study gestational endocrine changes and glucose homeostasis in general and insulin-
stimulated glucose uptake in particular. 
x to study exercise during pregnancy in women with high pre-pregnancy risk of 
developing GDM, such as increased BMI, previous GDM and a family history of 
T2DM. 
x to study whether an early intervention including a consultation with a physiotherapist 
focusing on ergonomics and exercise instructions can prevent development of LPP and 
sick leave due to LPP. 
x to study the efficacy of identify women at risk of LPP and to offer an individual 
follow-up.  
x to study the etiology and pathophysiology of pregnancy related LPP. 
x to study if PFMT in pregnancy can reduce AI in pregnancy. 
x to study whether a dose-response or a threshold of physical activity and exercise 
training in pregnancy exists. 
  
In this thesis, only short-term results are reported. Though, it is of importance to study the 
effects of regular exercise including PFMT during pregnancy on duration of labor, and long-
term effects for both mother and child. In the TRIP trial there is ongoing postnatal 
assessments of growth and development of the children. In addition, the health of the mother 
is assessed. The follow-up is planned up to 20 years of age of the offspring and will give 
important information about the possible long-term effects of exercise during pregnancy.   
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 ABSTRACT 
 
Objective: To assess if pregnant women following a general exercise course including pelvic 
floor muscle training (PFMT) were less likely to report urinary and anal incontinence in late 
pregnancy than a group of women receiving standard care. 
Design: A two-armed, two-center randomized controlled trial. 
Setting: Trondheim University Hospital (St. Olavs Hospital) and Stavanger University 
Hospital in Norway. 
Population: A total of 855 women were included in this trial.  
Methods: The intervention was a 12-week exercise program, including PFMT, conducted 
between week 20 and 36 of pregnancy. One weekly group session was led by physiotherapists 
and home exercises were encouraged at least twice a week. Controls received regular 
antenatal care. 
Main Outcome Measures: Self-reported urinary- and anal incontinence after the intervention 
period (at 32-36 weeks of pregnancy). 
Results: Fewer women in the intervention group reported any weekly urinary incontinence 
(11% vs. 19%, p = 0.004). Fewer women in the intervention group reported fecal incontinence 
(3% vs 5%), but this difference was not statistically significant (p = 0.18). 
Conclusions: The present trial indicates that pregnant women should exercise, and in 
particular do PFMT to prevent and treat urinary incontinence in late pregnancy. Thorough 
instruction is important and specific pelvic floor muscle exercises should be included in 
exercise classes for pregnant women. The preventive effect of PFMT on anal incontinence 
should be explored in future trials. 
Keywords: Exercise, pregnancy, pelvic floor muscle training, incontinence, prevention, 
treatment. 
Clinical trial registration: www.clinicaltrials.gov, NCT00476567. 
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 INTRODUCTION 
 
Pregnancy and delivery are risk factors for urinary and anal incontinence in later life.1,2 
Urinary incontinence is defined as “complaint of involuntary loss of urine”,3 while the term 
anal incontinence is defined as “complaint of involuntary loss of feces or flatus”.3  
 
The pelvic floor is an important part of the continence mechanisms.4 Contraction of the pelvic 
floor muscles (PFM) causes an inward lift and squeeze around the urethra, vagina and 
rectum,5 resulting in closure, stabilization, and resistance to downward movement.6 
Randomized controlled trials have documented the effects of intensive pelvic floor muscle 
training (PFMT) and close follow-up of physiotherapists in prevention and treatment of 
pregnancy related urinary incontinence.7-11 Nevertheless, one Cochrane review and two other 
systematic reviews conclude that the effect of PFMT during pregnancy to prevent urinary and 
anal incontinence still is open to question.12-14 The Cochrane review strongly recommends 
that all future trials of PFMT during pregnancy should collect data on fecal incontinence, and 
highlights the need for large, pragmatic trials of population-based approaches, using intensive 
PFMT and recruiting antenatal women regardless of continence status or parity.12 There is a 
lack of trials investigating the effect of implementing PFMT in a more general training 
program for pregnant women. 
 
We conducted the present study as one part of a randomized controlled trial aimed to 
investigate the effects of regular exercise during pregnancy in prevention of pregnancy-related 
diseases and complications during labour. The primary outcome was gestational diabetes and 
glucose metabolism.15 Another important research question was whether it was possible to 
prevent urinary and anal incontinence by including specific PFM exercises in the general 
exercise course, to improve the continence mechanisms before the problem arise (primary 
prevention), and to detect incontinence at an early stage and thereby stop the development of 
the condition (secondary prevention).  
 
The aim of this study was to assess if pregnant women following a general exercise course 
including PFMT, were less likely to report urinary and anal incontinence in late pregnancy 
than a group of women receiving standard care.  
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 METHODS 
 
We conducted a two-armed, two-center randomized controlled trial of a 12-week regular 
exercise program versus standard antenatal care. The procedures followed were in accordance 
with ethical standards of research and the Helsinki declaration. The women received written 
information about the trial, and they signed informed consent forms. The participants were not 
compensated financially. The study was approved by the Regional Committee for Medical 
and Health Research Ethics (REK 4.2007.81) and registered in Clinical trial gov (NCT 
00476567). 
 
Pregnant women booking for routine ultrasound at Trondheim University Hospital (St. Olavs 
Hospital) and Stavanger University Hospital were invited to participate in the trial. Women in 
Trondheim were recruited from April 2007 to June 2009, and women in Stavanger were 
recruited from October 2007 to January 2009. More than 97% of Norwegian pregnant women 
attend a routine scan at around 18 pregnancy weeks, and the exams are free of charge. During 
the inclusion period approximately 12 000 pregnant women had routine scans at the two 
hospitals. Inclusion criteria were age  18 years and a singleton live fetus. Exclusion criteria 
were high-risk pregnancies and/or diseases that could interfere with participation. For 
practical reasons we also excluded women who lived too far from the hospitals to attend 
weekly training groups (more than 30 minutes drive).  
 
Concealed randomization in blocks of 30 was performed at the Unit for Applied Clinical 
Research, Norwegian University of Technology and Science, by a web-based computerized 
procedure. The staff involved with training or outcome assessments had no influence on the 
randomization procedure. Because of the nature of the study it was not blinded.  
 
Women in the intervention group received a standardized exercise program including aerobic 
activity, strength training (including specific PFM exercises) and balance exercises. The 
training protocol followed recommendations from The American College of Obstetricians and 
Gynecologists and the Norwegian National Report on Physical Activity and Health.16,17 
Training sessions of 60 minutes in groups of 8-15 women instructed by a physiotherapist were 
offered once a week over a period of 12 weeks (between 20 and 36 pregnancy weeks). Each 
group session consisted of three parts: 
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 1) 30-35 minutes low impact aerobics (no running or jumping). Step length and body rotations 
were reduced to a minimum, and crossing of legs and sharp and sudden changes of position 
were avoided. The aerobic dance program was performed at moderate intensity, defined as 13 
and 14 on Borg’s rating scale of perceived exertion.18  
2) 20-25 minutes strength exercises using body weight as resistance, including exercises for 
the upper and lower limbs, back extensors, deep abdominal muscles and pelvic floor muscles. 
Three sets of ten repetitions of each exercise were performed. 
3) 5-10 minutes of light stretching, body awareness, breathing and relaxation exercises. 
 
In addition, women were encouraged to follow a written 45 minutes home exercise program 
including PFMT at least twice a week (30 minutes endurance training and 15 minutes strength 
and balance exercises). 
 
Women in the intervention group were individually instructed in pelvic floor anatomy and 
how to contract the pelvic floor muscles correctly by a physical therapist. Correct contraction 
was controlled by vaginal palpation. The PFMT followed principles for increasing strength of 
skeletal muscles.19 Women were encouraged to perform three sets of eight to twelve close to 
maximums contractions of the PFM and were encouraged to hold the contraction for six to 
eight seconds and if possible to add three fast contractions at the end of the contraction.20 
PFMT was performed in different positions with legs apart to emphasise specific strength 
training of the pelvic floor muscles and relaxation of other muscles. 
 
Adherence to the protocol was defined as exercising three days per week or more on moderate 
to high intensity. Performing the exercise program was strongly emphasized and recorded in 
the women's personal training diary and through reports from the physiotherapists leading the 
training groups.  
 
Women in the control group received standard antenatal care and the customary information 
given by their midwife or general practitioner. They were not discouraged from exercising on 
their own. Women in both groups received written information and recommendations on 
PFMT, diet and pregnancy related lumbopelvic pain. The PFMT brochure includes detailed 
information about the pelvic floor and an evidence-based PFMT program.9 
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 Pre-tests were done between 18-22 weeks and post-tests between 32-36 weeks of pregnancy. 
Main outcomes were urinary and anal incontinence measured by self-reports. All participants 
answered a questionnaire including questions related to urinary (Sandvik’s severity index)21,22 
and anal (St. Marks score)23 incontinence at inclusion (18-22 weeks) and at the end of the 
intervention period (32-36 weeks). Women were asked to report their urinary leakage when 
A) coughing / sneezing / laughing, B) when being physically active (running or jumping), C) 
when sudden changes in position / lifting or D) leakage accompanied by a strong urgency to 
void. Answer alternatives were “Yes” or “No. Urinary leakage was subclassified according to 
the definitions given in the standardized terminology of lower urinary tract symptoms.3 
Women confirming any type of urinary leakage (alternative A, B, C or D) were referred to as 
having urinary incontinence (UI). Women confirming loss of urine in association with 
alternative A, B or C were defined as having stress urinary incontinence (SUI), while women 
confirming loss of urine with alternative D were defined as having urge urinary incontinence 
(UUI), The outcome measures of UI were further divided into two severity categories in 
respect to frequency, “urinary leakage < once per week” or “urinary leakage  once per week 
(severe UI)”. Anal incontinence was registered as fecal and flatal incontinence during the 
previous four weeks based on one question from the St. Marks score.23 Women reporting 
leakage of solid and/or liquid stool during the last four weeks were categorized as fecal 
incontinent, and women reporting flatus during the last four weeks were categorized as flatal 
incontinent.  
 
Frequency, intensity and type of physical activity including PFMT were recorded for both 
groups at inclusion and follow-up by self reports in a questionnaire. In addition, women in the 
intervention group registered PFMT in a training diary. 
 
Based on a prevalence estimate of gestational diabetes of 9 % with a reduction to 4% (primary 
outcome of the trial), a study population of 381 patients in each group was needed in a two-
sample comparison test with a 5% significance level and a power of 0.80. This sample size 
was able to detect a 0.2 SD difference on continuous variables with a power of 0.80. Given 
the study population, we had a power of 0.79 to detect a risk reduction in urinary incontinence 
of 10% from 50% to 40% in the two groups. 
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 The statistical analyses were performed with SPSS version 19. The data were analyzed 
according to the “intention–to-treat” principle using Chi squared test and binary logistic 
regression. The results were presented as crude and baseline adjusted estimates with 95% 
confidence intervals.  
 
Women in intervention and control groups were primarily analyzed according to type of 
incontinence (UI, SUI, UUI, fecal and flatal incontinence). Subgroup analyses were based on 
urinary, fecal and flatal continence status at the time of inclusion, estimating primary and 
secondary preventive effects of the intervention.  
 
 
RESULTS 
 
In all, 875 women consented to participate in the trial. Twenty women were excluded or 
withdrew before the first examination: thirteen did not meet the inclusion criteria, five 
miscarried and two had twin pregnancies. A total of 855 women were randomly allocated to 
an intervention group or a control group (Figure 1). However, 32 women in the intervention 
group and 61 in the control group were lost to follow-up. Data from 397 intervention group 
women and 365 control group women were included in a complete case analysis. 
 
The groups were similar in baseline characteristics except for severe UI and SUI, which were 
more frequent in the control group (p = 0.05 and p = 0.01) (Table 1). After the intervention 
period significantly less women in the intervention group reported UI and SUI, irrespective of 
severity (Table 2). The findings were consistent when adjusting for baseline values. A lower 
proportion of women in the intervention group (3%) than the control group (5%) reported 
fecal incontinence, however the difference was not statistically significant (Table 2). There 
were no differences in weight or BMI between groups at follow-up. 
 
Subgroup analyses were done for nulliparous and multiparous women. At baseline the 
prevalences of severe UI and SUI were lower in the intervention group among nulliparous 
women. After the intervention (at 32-36 weeks of pregnancy) the prevalence of UI was 35% 
vs. 47% with OR adjusted for baseline values 0.6 (95% CI 0.4, 0.9; p=0.03) in the 
intervention and control group among nulliparous women, and severe UI was 6% vs. 14% 
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 with OR adjusted for baseline values 0.4 (95% CI 0.2, 0.9; p=0.02). In multiparous women 
the prevalence of fecal incontinence at 32-36 weeks of pregnancy was lower in the 
intervention group, 3% vs. 8% with OR adjusted for baseline values 0.2 (95% CI 0.1, 0.8; 
p=0.03). No other significant differences were seen in a subgroup analysis according to parity. 
  
Baseline characteristics of subgroups based on groups stratified according to urinary 
continence status at inclusion are presented in Table 3. Sixty-nine percent of the continent 
women and 40% of the incontinent women were nulliparous. The subgroup analyses showed 
that in women who were continent for urine at inclusion, the proportions of women reporting 
SUI  once per week and UUI were significantly lower (p = 0.03 and p = 0.006) in the 
intervention group after the intervention period (Table 4). Furthermore, in women in either 
group who were incontinent for urine at inclusion, the proportion reporting UI, UI  once per 
week and SUI after the intervention period was lowest in the intervention group (p = 0.002, p 
= 0.03 and p = 0.007). The findings were consistent when adjusting for baseline values (Table 
4).  
 
There were no differences in age, parity, weight and BMI based on groups stratified according 
to fecal continence status at inclusion. Among fecal continent women at inclusion, 2% (8/359) 
in the intervention group and 4% (13/332) in the control group reported fecal incontinence at 
follow-up with an OR and 95% CI of 0.6 (0.2, 1.4; p = 0.20). Among women reporting fecal 
incontinence at inclusion, 19% (4/21) in the intervention group and 20% (3/15) in the control 
group reported fecal incontinence at follow-up with and OR and 95% CI of 0.9 (0.2, 5.0; p = 
0.94). 
 
Women reporting flatal incontinence at inclusion were younger than flatal continent women 
(30.0 ± 4.1 versus 30.7 ± 4.4) and a larger proportion was nulliparous (65% versus 54%). 
Among flatal continent women at inclusion the proportion flatal incontinence in both groups 
after the intervention period were 21% (58/275 versus 53/258) with an OR and 95% CI of 1.0 
(0.7, 1.6; p = 0.88). Among women reporting flatal incontinence at inclusion, 69% (75/109) in 
the intervention group and 74% (69/93) in the control group reported flatal incontinence at 
follow-up with and OR and 95% CI of 0.8 (0.4, 1.4; p = 0.40). 
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 In the intervention group, 95% reported weekly PFMT at follow-up compared to 79% in the 
control group (p < 0.001). The proportion of intervention group women performing PFMT 
three times per week or more was 67% compared to 40% in the control group (p < 0.01).  
 
Adherence to the general exercise protocol (exercising three days per week or more at 
moderate to high intensity) in the intervention group was 55% (n = 217). For comparison 10% 
in the control group exercised three days per week or more at moderate to high intensity at 
follow-up (p < 0.001). In the intervention group, 72% exercised at least once per week. UI 
and anal incontinence were not more frequent among the protocol adherent intervention group 
women (n = 217) compared to the total control group at the end of the intervention.  
 
No serious adverse events related to physical exercise were seen, and the outcomes of 
pregnancy were similar in the two groups.15  
 
 
DISCUSSION 
 
This trial demonstrates that pregnant women following a 12-week regular exercise course 
including PFMT were less likely to report UI and SUI in late pregnancy than women given 
standard care including written instructions in PFMT. Among pregnant women being 
continent for urine at the time of inclusion, significantly fewer women in the intervention 
group reported SUI once per week or more and UUI at follow-up, indicating a primary 
preventive effect of the intervention. In the subgroup of pregnant women categorised as 
incontinent for urine at inclusion, significantly fewer women in the intervention group 
reported UI, SUI once per week or more and SUI in late pregnancy compared to women in the 
control group (secondary prevention). A lower proportion of women in the intervention group 
reported fecal incontinence compared to the control group, however the difference was not 
statistically significant. A subgroup analysis of multiparous women showed a significantly 
lower prevalence of fecal incontinence in the intervention group after the intervention. 
 
Strengths of the present trial are the large number of participants, the high follow-up rate and 
the use of a computerized randomization procedure. Despite the randomized design some of 
the baseline characteristics were significantly different between groups. This was probably 
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 due to chance and accounted for in the statistical analysis. The investigators were aware of 
group allocation. However, since prevalence of incontinence was based on self-reports the 
lack of blinding of investigators should not have had any impact on the results.  The 
prevalence of urinary leakage in pregnancy has been reported to vary between 9% and 
74%.24,25 This variation is probably due to different study populations (various proportions of 
nulliparous/parous women), different definitions of incontinence (self-reports or standardised 
pad tests), and different pregnancy lengths. In the Norwegian Mother and Child Cohort Study 
including 43,279 women from 1999-2006, 58% of the women reported any UI and 35% any 
UI weekly or more in pregnancy week 30.26 Anal incontinence is less studied in pregnancy, 
but a prevalence of 6% in late pregnancy has been reported.27 
 
The prevalence of urinary leakage in mid- and late pregnancy in the present trial was lower 
than in a previous trial conducted in the same geographically area ten years ago using the 
same outcome measures to classify continent and incontinent women as in the present trial.9 
Mørkved et al found that 32% of nulliparous women in the intervention group and 48% in the 
control group reported leaking urine once per week or more in pregnancy week 36.9 In the 
present trial leaking urine once per week or more in pregnancy week 32-36 was reported by 
6% vs. 14% nulliparous women. Since PFMT is known to have a high cure rate,28 the 
difference between studies may be due to an increased focus on PFMT in pregnant women 
and health care professionals, following the results of the previous trial. In the current trial 
60% of the study participants reported doing any PFMT at the time of inclusion, and 25% 
reported doing PFMT three times per week or more. In the previous trial 30% performed any 
PFMT at inclusion.9 
 
The success of training depends on the ability to effectively contract the PFM. It is estimated 
that 30 % of women are unable to contract the PFM on the first attempt.29,30 Bump et al29 
found that only 49 % performed an ideal voluntary PFM contraction after brief standardized 
verbal instruction. In the present trial all women in the intervention group were individually 
instructed in pelvic floor anatomy and correct contraction was controlled with vaginal 
palpation. Women in both groups received written information of PFMT including an 
evidence-based exercise program, and at follow-up, the number of women performing PFMT 
had increased in both groups. At follow-up, a large proportion of women in the control group 
reported doing regular PFMT during the intervention period. Still, the intervention group 
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 demonstrated significantly less UI in late pregnancy. This finding suggests that thorough 
instructions in correct PFM contraction, intensive PFMT and close follow-up are important to 
increase the success rate. 
 
Another possible explanation of a low prevalence in the current trial may be differences in 
study populations. In the trial by Mørkved et al9 pregnant women were invited to participate 
with the explicit goal to study the effects of PFMT on urinary incontinence. The aims of the 
current trial were to assess effects of a more general exercise program on several pregnancy-
related conditions. Women experiencing urinary leakage may have been more likely to sign 
up in the previous trial aiming to improve continence, and women with severe urinary leakage 
may have been less likely to sign up for a general exercise trial including activities or 
situations that often cause incontinence. In the previous trial 32 % of the study population 
reported weekly UI at inclusion9 compared to 13 % in the current trial. The study population 
in the present trial was found to be representative for pregnant women in Norway regarding 
age, BMI, parity and level of exercise.15 
 
Three previous trials have addressed primary prevention of UI during pregnancy.8,31,32 Two 
trials reported highly significant preventive effects of PFMT.8,32 The third trial had conflicting 
results,31 but the response rate of participants was low (ca 50%). The Cochrane review 
addressing prevention of urinary- and fecal incontinence included mixed prevention and 
treatment trials.12 Data from subgroups of previously continent women7,9 were added to the 
analyses of a primary preventive effect of PFMT on UI, and the results documented that for 
women having their first baby, antenatal PFMT appears to reduce the prevalence of urinary 
incontinence in late pregnancy.12 Thus, the review suggested new large, pragmatic trials using 
intensive PFMT and recruiting antenatal women regardless of continence status or parity and 
collecting data on both urinary and fecal incontinence.12 Subgroup analyses in the present trial 
support the Cochrane review conclusions that the prevention and treatment effects on UI in 
late pregnancy were predominantly seen in women having their first baby with a 40-60% 
reduction in risk.  
 
Anal incontinence is less prevalent, but this condition is clearly a social and psychological 
burden, which reduces the quality of life.33 The preventive effect of PFMT on the 
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 development of anal incontinence is sparsely studied. One previous trial included PFMT in a 
general fitness program. This trial demonstrated no difference in urinary- or anal incontinence 
between intervention and control group. However, this trial was underpowered and included 
no control of the women’s ability to contract the PFM correctly.34  
 
In the present trial, the proportion of women reporting fecal incontinence in the intervention 
group was reduced from 5% to 3% after the intervention period. In the control group the 
proportion reporting fecal incontinence increased from 4% to 5% at follow up. Although this 
difference was not statistically significant, it may suggest a possible clinically significant 
effect of the intervention. Another interesting finding was the preventive effect on fecal 
incontinence in multiparous women. This finding indicates that in women with possible 
previous birth related injury to the PFM, PFMT might prevent fecal incontinence in a later 
pregnancy. 
 
In the present trial, women in the intervention group were encouraged to follow a general 
exercise protocol three times per week or more during the 12-week intervention period. 
Fiftyfive percent of the women in the intervention group adhered to the protocol and 72% of 
intervention group women exercised at least once per week. For comparison, 10% of control 
group women reported exercising three days per week or more and 30% at least once per 
week. Women being physically active are more frequently exposed to higher and more 
repetitive increases in abdominal pressure compared to more sedentary women. The exercise 
protocol in the present trial was physical fitness exercises designed for pregnant women and 
did not include running or jumping. However, the aerobic part of the program consisted of 
weight bearing exercises causing increased abdominal pressure and increased risk of urinary 
leakage. Nevertheless, fewer women in the intervention group reported UI, and women 
adhering to the exercise protocol reported less UI than non-adherent women in the 
intervention group at follow-up. 
 
In addition to better structural support for the bladder neck with PFMT, the intervention group 
may have developed increased awareness and skill of timing the contraction with the event 
that elicits leakage. Miller et al35 found that 80% of women with de novo stress incontinence 
in pregnancy week 35 were able to reduce leakage during coughing by using the Knack 
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 maneuver (i.e. tighten the PFM in preparation for a known leakage-provoking event), with 
55% eliminating leakage completely.  
 
An epidemiologic study including 27,936 women reported a prevalence of any urinary 
incontinence of 25% in the adult population, with the prevalence of incontinence increasing 
with age.36 Among nulliparous women in that study (n = 3,339) 10% reported UI.37 Data 
suggest that pregnancy contributes to pelvic floor dysfunction later in life,38 and that the first 
pregnancy and delivery is associated with a high prevalence of objective and subjective bowel 
dysfunction.39 In a cohort study it was found that most women experiencing postpartum UI 
had symptoms of UI during the third trimester.25 Another study found that five years after the 
first delivery, 33% of women reported UI.40 Although UI is common, it reduces quality of life 
and affects social, physical, occupational and leisure activities.41 The present trial 
demonstrates that PFMT during second half of pregnancy reduced the prevalence of UI in late 
pregnancy. However, it is important to assess any possible long-term effects postpartum. 
When comparing the prevalence of UI in the present trial with one previous trial from the 
same area,9 we found a significant reduction over the last ten years. This may be due to 
different study populations, but may also be due to increased awareness and knowledge about 
prevention and treatment of UI among health care professionals and the general population, 
indicating a preventive effect of information, instructions and encouragement to exercise the 
PFM. 
 
The prevalence of fecal incontinence during pregnancy is low, and the present trial was 
slightly underpowered to assess fecal incontinence properly, as shown by the wide confidence 
intervals. One important issue for future research is to assess if PFMT in pregnancy can 
reduce fecal incontinence in pregnancy. Further, it is important to assess the effects of regular 
exercise including PFMT during pregnancy on duration of labour, the long-term effects on 
urinary- and anal continence and to investigate the associations between outcome, prior 
continence status and parity. 
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 CONCLUSION 
 
The results from the present trial indicate that pregnant women should do PFMT to prevent 
and treat UI in late pregnancy. Thorough instruction in correct PFM contraction and PFMT is 
important, and specific PFM exercises should be included in exercise classes for pregnant 
women. Any possible long-term effects on UI and the preventive effect of PFMT on anal 
incontinence should be further explored. 
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 Table 1. Baseline maternal characteristics of the study population. 
 
 Intervention group Control group 
Maternal characteristics (n = 429) (n = 426) 
Mean age – years 30.5 ± 4.4 30.4 ± 4.3 
Parity – no. (%)   
      0 247 (58) 239 (56) 
      1 125 (29) 129 (30) 
      2+ 57 (13) 58 (14) 
Previous vaginal delivery – no. (%) 168 (39) 171 (40) 
Gestational week at booking 20.3 ± 1.5 20.3 ± 1.7 
Booking BMI – kg/m2 24.7 ± 3.0 25.0 ± 3.4 
Booking weight – kg 70.4 ± 9.8 70.8 ± 10.3 
Exercise regularly – no. (%) 228 (53) 216 (51) 
Exercise regularly 3 times per week at 
moderate to high intensity – no. (%) 
60 (14) 50 (12) 
PFMT – no. (%) 249 (59) 272 (64) 
PFMT 3 times per week – no. (%) 101 (24) 110 (26) 
UI * 172 (40) 180 (43) 
UI 1 times per week – no. (%) * 44 (10) 63 (15) 
SUI † 108 (26) 120 (30) 
SUI 1 times per week – no. (%) † 23 (5) 43 (10) 
UUI 16 (4) 16 (4) 
UUI 1 times per week – no. (%) 1 (0.2) 2 (0.5) 
Fecal incontinence – no. (%) ‡ 22 (5) 17 (4) 
Flatal incontinence – no. (%) § 118 (28) 111 (27) 
Plus-minus values are means ± SD. 
BMI denotes Body Mass Index, PFMT pelvic floor muscle training, UI any urinary 
incontinence, SUI stress urinary incontinence and UUI urge urinary incontinence. 
* Data missing in 0.5% of cases. 
† Data missing in 3.6% of cases. 
‡ Data missing in 2.5% of cases. 
§ Data missing in 2.0% of cases. 
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 Figure legend 
Figure 1. Flow chart of study participants. 
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 Appendix I 
 
SJEKKLISTE FOR INKLUSJON 
- ”Effekt av trening under svangerskap” 
 Spørsmål JA NEI 
1. Kvinne >18 år? Ɣ  
2. Bopæl nær sykehuset (<20 km) Ɣ  
3. Kaukasisk, snakker norsk Ɣ  
4. Normal graviditet med lav risiko for 
svangerskapskomplikasjoner 
Ɣ  
5. Informert skriftlig samtykke Ɣ  
6. Diabetes?  Ɣ 
7. Tidligere alvorlig 
svangerskapskomplikasjoner 
-preterm fødsel før uke 34 
-tidlig innsettende og alvorlig preeklampsi 
(dvs forløsning før uke 34 eller eklampsi og 
HELLP syndrom) 
-alvorlig vekstretardasjon hos foster 
 Ɣ 
8. Alvorlig kroniske sykdommer 
-astma 
-hjertesykdom 
-SLE 
-hypertoni (medikamentelt behandlet før 
graviditet) 
-alvorlig nyresykdom 
 Ɣ 
9. Kjent alkohol- eller 
medikamentmisbruk 
 Ɣ 
10. Flerlinger  Ɣ 
11. Fostermisdannelser  Ɣ 
12. Placenta previa  Ɣ 
13. Forhøyet blodtrykk (>140/90) i minst 
to målinger før sv.uke 20 
 Ɣ 
14. Identifisert høy risiko for preterm 
fødsel 
-kort livmorhals 
-rikelige vaginalblødninger med påvist 
retroplacentært hematom 
-vannavgang eller fostervannslekkasje 
 Ɣ 
15. Uegnet til å delta av enhver annen 
årsak 
 Ɣ 
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 Appendix II 
 
BORGS SKALA 
 
 
INSTRUKSJON 
 
 
I løpet av treningen vil vi at du skal være oppmerksom i 
forhold til hvor anstrengende du føler at treningen er. Denne 
følelsen skal gjenspeile totalsummen av anstrengelse og 
utmattelse, ved å kombinere alle følelser av fysisk stress, 
påkjenning og utmattelse. Ikke bry deg om hver enkelt faktor 
slik som smerte i beina, kortpusthet eller øvelsens intensitet, 
men forsøk å konsentrere deg om den totale indre følelsen av 
anstrengelse. Prøv å ikke undervurdere eller overvurdere din 
følelse av anstrengelse; men vær så presis som du kan. 
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 BORGS SKALA 
 
6 
 
7 Meget, meget lett 
 
8 
 
9  Meget lett 
 
10 
 
11  Ganske lett 
 
12 
 
13  Litt anstrengende 
 
14 
 
15  Anstrengende 
 
16 
 
17  Meget anstrengende 
 
18 
 
19  Svært anstrengende 
 
20 
  
189
 Appendix III 
 
 
PROGRAM FOR EGENTRENING 
 
 
Egentreningsprogrammet består av to deler, både utholdenhetstrening (30 min) og 
styrketrening (ca 15 min). 
 
Utholdenhetstreningen kan oppnås på ulike måter, men det er viktig at du finner en 
treningsform som passer deg. Du kan gå rask tur, jogge, sykle, svømme eller annet. Det 
viktigste er at du får økt puls over lengre tid (30 min). Intensiteten skal være såpass at det 
oppleves litt anstrengende, det vil si at du skal bli varm og svett. 
 
Styrketreningsprogrammet består av sju ulike øvelser som har til hensikt å styrke ben, armer, 
rygg, mage, bekkenbunnsmuskulatur samt trene balansen. På alle øvelsene er det beskrevet 
flere mulige utgangsstillinger for gjennomføring. Det er viktig at du prøver deg litt fram og 
finner den utgangsstillingen som passer best for deg. Spør gjerne fysioterapeuten som leder 
gruppetreningen om hjelp til dette. Det vil være naturlig at en utgangsstilling som passer deg 
bra i begynnelsen av treningsperioden, passer mindre bra mot slutten av treningsperioden 
enten fordi magen har blitt større, du har blitt sterkere eller noe oppleves ubehagelig. Da kan 
du bytte til en annen utgangsstilling. 
 
Det er viktig at du klarer å gjennomføre hver øvelse med 8-12 repetisjoner og 3 serier. 
 
Underveis eller etter treningen skal du ikke ha noe ubehag. Det er naturlig å være litt støl i 
etterkant av treningen, spesielt i oppstartsfasen, men du skal ikke ha smerter. Ta kontakt 
dersom noe medfører ubehag. 
 
Hjemmetreningsprogrammet skal gjøres to dager i uka i tillegg til en time i gruppetrening 
med fysioterapeut. 
 
OBS! Husk å krysse av på treningsdagboken når du har gjennomført treningen. 
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 Øvelse 1 
 
KNEBØY 
 
Alt. A) 
Stå med skulderbreddes avstand med føttene. La armene henge 
ned eller plasser de på hoftekammen. Bøy ned i hofte- og 
kneledd med ”knær over tær”, og rumpa ut bak som om du skal 
sette deg på en stol. Stram setet og strekk opp igjen til stående 
stilling. Varier tyngden med hvor langt du bøyer ned. 
 
Øvelsen kan også gjøres stående på balanseputa. 
 
 
 
 
 
 
 
 
Alt. B) 
Strekk armene fram mens du bøyer ned. 
 
Øvelsen kan også gjøres stående på balanseputa. 
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 Øvelse 2 
 
”PLANKEN” (gjøres tre ganger) 
 
Alt. a) 
Grunnstilling 
Stå på alle fire (knær og strake armer) med 
ryggen i nøytral stilling. Trekk navlen inn mot 
ryggen (nedre del av magen) og hold posisjonen i 
10-15 sek. 
 
 
 
 
 
 
Alt. b) 
Start med grunnstillingen. Trekk navlen inn mot 
ryggen (nedre del av magen) og finn stillingen 
som bildet viser: Stå på knær og strake armer, 
hold kroppen strak og ryggen i nøytral stilling. 
Hold posisjonen i 10-15 sek. 
 
 
 
 
 
Alt. c) 
Start med grunnstillingen. Trekk navlen inn mot 
ryggen (nedre del av magen) og finn stillingen 
som bildet viser: Stå på tærne og albuene, hold 
kroppen strak og ryggen i nøytral stilling. 
Hold posisjonen i 10-15 sek. 
 
 
 
OBS!  
Pust godt mens du gjør øvelsen (ikke hold pusten)! 
 
Dersom du ikke klarer å holde posisjonen må du gå bytte til en enklere utgangsstilling 
eller korte ned holdetiden! 
 
Dersom du har god kontroll på øvelsen kan du gjøre den tyngre ved å stå på 
balanseputa. Ha puta under knærne i utgangsstilling a og b, eller under tærne i 
utgangsstilling c. 
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 Øvelse 3 
 
ARMHEVINGER 
 
Alt. a) 
Stå med føttene i skulderbreddes avstand et stykke ut fra 
veggen. Len deg mot veggen på strake armer med strak kropp. 
Trekk navlen inn mot ryggen (nedre del av magen, se 
”Plankeøvelsen”). Gjør armhevinger mot veggen. Varier 
tyngden med å stå nærmere veggen (lettere) eller lenger fra 
veggen (tyngre). 
 
 
 
 
 
 
 
 
 
 
 
Alt. b) 
Stå på knær og strake armer. Trekk navlen inn 
mot ryggen (nedre del av magen, se 
”Plankeøvelsen”). 
Gjør armhevinger med knærne i gulvet og strak 
kropp. 
 
 
 
Alt. c) 
Stå på tær og strake armer. Trekk navlen inn mot 
ryggen (nedre del av magen, se ”Plankeøvelsen”). 
Gjør armhevinger med tærne i gulvet og strak 
kropp. 
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 Øvelse 4 
 
DIAGONALLØFT 
 
 
Alt. a) 
Stå på knær og strake armer med hodet i nøytral 
stilling. Trekk navlen inn mot ryggen (nedre del 
av magen, se ”Plankeøvelsen”). Løft diagonalt 
arm og ben til vannrett stilling. 
 
 
 
 
Alternativ ved smerter: 
 
Alt. b) 
Stå på knær og strake armer med hodet i nøytral 
stilling. Trekk navlen inn mot ryggen (nedre del 
av magen, se ”Plankeøvelsen”). Løft en og en 
arm strakt frem. 
 
 
 
 
 
 
 
 
 
 
 
 
Alt. c) 
Stå på knær og strake armer eller på albuene med hodet i nøytral stilling. Trekk navlen inn 
mot ryggen (nedre del av magen, se ”Plankeøvelsen”). Strekk et og et ben vannrett bakover. 
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 Øvelse 5 
 
BEKKENBUNNENS MUSKLER 
 
Løft opp og inn rundt urinrør, skjede og endetarm uten å spenne mage, sete og lår. Ta i så 
hardt du kan under hver sammentrekning og forsøk å holde i 6-8 sekunder før du slipper rolig 
ned. Pust rolig ut og inn, både under og mellom muskelsammentrekningene. Velg en eller 
flere av disse utgangsstilingene: 
 
Alt. a) 
Sitt med bena fra hverandre i skredderstilling med rett 
rygg. Trekk sammen rundt åpningene i bekkenbunnen. 
 
 
 
 
 
 
 
 
 
 
Alt. b) 
Stå med bena fra hverandre, kjenn etter at du er slapp i 
setemusklene mens du trekker sammen i bekkenbunnsmusklene. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Alt. c) 
Stå på alle fire med knærne ut til siden og føttene 
sammen. Hev bekkenbunnen opp og innover. 
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 Øvelse 6 
 
SKRÅ BUKMUSKLER 
 
Alt. a) 
Skrå sit-ups i sittende. Sitt i skredderstilling med 
rett rygg. Press motsatt arm og kne mot 
hverandre. Bruk strak arm og press diagonalt. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Alt. b) 
Skrå sit-ups i ryggliggende. Ligg på ryggen med bøyde ben og korsryggen i kontakt med 
gulvet. Løft overkroppen litt opp fra underlaget slik at skulder peker mot motsatt kne. 
 
 
 
OBS! 
Noen gravide kan bli uvel eller svimmel av å ligge på ryggen. Dersom det gjelder deg 
bør du trene de skrå bukmusklene i utgangsstilling a. 
 
Trekk sammen bekkenbunnsmusklene samtidig som du gjør skrå sit-ups.
196
 Øvelse 7 
 
BALANSEØVELSER 
 
Alt. a) 
Stå med begge ben på balanseputa. Stabiliser mage og rygg ved 
å trekke navlen inn mot ryggen (nedre del av magen, se 
”Plankeøvelsen”). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Alt. b) 
Stå med ett ben på balanseputa. Stabiliser mage og rygg ved å 
trekke navlen inn mot ryggen (nedre del av magen, se 
”Plankeøvelsen”). 
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Alt. c) 
Stå på balanseputa i valgfri utgangsstilling. Stabiliser mage og 
rygg ved å trekke navlen inn mot ryggen (nedre del av magen, se 
”Plankeøvelsen”). Hold balansen mens du: 
9 Lukker øynene 
9 Strekker deg i ulike retninger 
9 Kaster en ball mot en vegg og tar imot 
9 Har en gjenstand i hånden og bytt over til andre hånden 
foran, over og bak kroppen 
9 Gjør knebøy (øvelse 1) med lukkede øyne 
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